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Heart rate variability(HRV) is a profound technique to assess autonomic nervous system 
(ANS). Therefore, HRV is widely used in different applications including recovery monitoring. 
Open chest surgery is relatively complex and lengthy. Open-chest surgery intrudes anat-
omy and physiology of the chest and significantly reduces the functions for a few days after the 
operation. 
 
In those recovery days, it is important to monitor the patient’s well beingness as well as autonomic 
nervous system function. HRV is a promising method for this purpose. The purpose of this study 
is to use HRV in evaluation of recovery phase of open chest surgery. 
 
The study population was 136 patients with elective heart surgery, pulmonary re-sections sur-
gery, and minor pleuropulmonary surgery. The measurements were conducted one day before 
the operation and for 1–3 days after the operation during the usual episode of treatment at the 
hospital. Simultaneous ECG signal was measured for 10 minutes. There were two equally sized 
subgroups A and B based on the type of given physiotherapy of randomized patients in these 
three surgery type groups. 
 
RR intervals of each measurement were calculated and by using those RR intervals, HRV pa-
rameters were found out for every measurements. Statistical tests were performed finding the 
significant difference between different measurement days. The significance level (p-value) was 
0.05. Statistical comparisons of HRV parameters between one day before surgery and 1-3 days 
after surgery were performed inside all patients as well as inside different specific patient group. 
Statistical tests between 1 day and 2-3 days after surgery as well as between 2 and 3 day after 
surgery were also performed. Statistical comparisons of HRV parameters between control group 
A and B were also performed inside all patients and inside different specific patient group. 
 
The results showed that there were significant differences in some HRV parameters between one 
day before and 1-3 days after the operation, especially, heart surgery group had strong significant 
differences among those days. The study finds no significant difference between intervention 
subgroups A and B except minor pulmonary surgery patients. The study indicates that some 
HRV parameters were significantly different due to open chest surgery. However, evaluating re-
covery phase need longer observation period. 
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1.    INTRODUCTION 
Cardiothoracic Surgery is the surgical treatment which is related with the treat-
ment of diseases affecting organs within thorax, mainly heart and lungs. Since 
second world war, cardiothoracic surgery rapidly grown surgery. The procedure 
of this surgery is relatively lengthy and complex. This surgery requires support 
from advanced forms of technology and intensive therapy for the patients is 
needed after surgery.[38] 
 
After the surgery, the patient usually spend five to seven days in the hospital. 
First 24 hours patient stay in intensive care unit, usually with a breathing tube. 
Anaesthesia will not have worn off, so patient will likely wake up after surgery in 
the Intensive Care Unit (ICU) room. When patients are able to breathe on their 
own way then breathing tube is removed. The heart rate, temperature, breathing 
status, blood pressure, pain level, chest tube drainage and other things are mon-
itored by trained nurses and personals. When the surgery team feels that patients 
are ready to move in another unit in hospital then patients move to another unit. 
However, monitoring patients keep going until patients are strong enough to leave 
the hospital. Recovery in the hospital days may include removing drainage tube, 
walking in the hallways, daily lab test and chest x-ray. The vital sign, breathing 
status, glucose and other things are monitored closely in those days.[47] 
 
The measure of variation in Heart Rate (HR) is called Heart Rate Variabil-
ity (HRV). The heart and Autonomic Nervous System (ANS) altogether control 
the heart rate of our human body. The Electrocardiogram (ECG) measure the 
heart signal which contains clearly recognizable QRS complex. The time differ-
ence between two conjugative QRS complex is called RR interval which is the 
main basis of HRV analysis. There are many signal processing and mathematical 
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methods which are applied to the RR interval signal to obtain different factors 
affecting the HRV.[22] 
 
The ANS controls mostly HRV and the efferent part of ANS can be divided into 
two opposing limbs. The sympathetic and parasympathetic nervous system exert 
opposite action on every most organs including heart. The HR fluctuation can be 
classified into the influence of sympathetic and parasympathetic nervous system 
with HRV analysis. With HRV analysis the different factors directly or indirectly 
affecting ANS can cause abnormal variation in the HR can be studied. 
 
Purpose of this study is to evaluate the recovery phase of thoracic surgery with 
HRV analysis. HRV analysis might be a novel and useful tool for monitoring the 
recovery phase of cardiothoracic surgery. It was expected, that HRV parameters 
are significantly changed and varied from before surgery day to after surgery 
days. Statistical analyses were also performed in this study.  
 
The study material was collected from Tampere University Hospital, Heart Cen-
ter, Finland during 2013-2016. The patients were adult thoracic surgery patients 
with various types of elective cardiac and pulmonary operations. Physiotherapy 
was provided throughout the episode of care and the ECG signal was measured 
one day before and for 1-3 days after the surgery. A physiotherapist preformed 
physiotherapy interventions and all the measurements at the Heart Center. The 
author processed and prepared that ECG signal for HRV analysis. Visual and 
statistical analysis were used for analysing the results.  
 
This paper is structured as follows. Chapter 2 discusses the theoretical back-
ground of this thesis which were studied doing this thesis work. Chapter 3 dis-
cusses the material and methods which were taken performing this thesis work. 
Chapter 4 presents the results which were got from this work. Chapter 5 dis-
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cusses the different important points of this whole thesis work. Chapter 6 sum-
marizes the outcomes and the whole document. References are included in the 
reference chapter. 
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2.    THEORITICAL BACKGROUND 
2.1 The Human Heart 
Heart is the core of cardiovascular system of human body which pumps and 
contracts deoxygenated blood to the lungs and oxygenated blood to the body. 
There are four chambers in heart: left atrium, left ventricle, right atrium and right 
ventricle (see Figure 1). Oxygen-poor blood enter into right atrium from the sys-
temic veins, superior vena cava brings oxygen-poor blood from the head and 
arms and the inferior vena cava brings oxygen-poor blood from the abdomen 
and legs. Then oxygen-poor blood  moves through tricuspid valve to right ventri-
cle. Deoxygenated blood pump out through pulmonic valve to lungs through pul-
monary arteries. The blood becomes oxygenated in the lungs and come back to 
the left atrium through pulmonary veins. Then, this rich-oxygenated blood move 
to left ventricle through mitral valve and pump out through semilunar valve to 
systemic arteries and body tissues. This is done regularly and continuously. The 
heart muscle is doing this pumping and contraction. All the components of in-
trinsic conduction system contain autorhythmic cardiac cells. These cells initiate 
and spread action potential throughout the heart.[11] 
 
 
Figure 1.   The human heart, Oxygen-poor blood colored as lighter blue and ox-
ygen-rich blood is colored as red. Taken from [3] 
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2.2  Autonomic Nervous System 
The Nervous system carries messages to and from brain and spinal cord to the 
different parts of our body which is a very complex network of nerves and 
cells[33]. The nervous system in our body is divided into two different kinds. 
One is Central Nervous System (CNS) and other one is Peripheral Nervous 
System (PNS) (see Figure 2). CNS includes brain and spinal cord. PNS in-
cludes Autonomic Nervous System (ANS) and Somatic Nervous System 
(SNS)[15]. 
                                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.    Structural classification of Nervous System. Central nervous system 
receives input via sensory fibers and it issues commands via motor fibers. The 
efferent and afferent fibers together form the nerves which constitute the periph-
eral nervous system. Modified from[28] 
 
Autonomic nervous system is a control system which controls body function au-
tomatically. It regulates the nerves of inner organs of our body which are not 
Central Nervous System 
   (brain and spinal cord) 
Peripheral Nervous System 
 (cranial and spinal nerves ) 
    Motor 
  (efferent) Sensory  
(afferent) 
   Sense 
   organs 
    Somatic 
   (voluntary)     
Skeletal muscles 
        Autonomic  
        (involuntary) 
Cardiac and smooth muscle, 
glands 
Sympathetic Parasympathetic 
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controlled consciously. Autonomic nervous system is divided into three different 
branches. One is sympathetic and other one is parasympathetic and another 
one is enteric.[33] 
 
Sympathetic nervous system relates with body’s flight or fight mood. Parasym-
pathetic relates with body's resting and normal mood. Enteric relates with diges-
tion. In this thesis work, sympathetic and parasympathetic nervous systems are 
studied. Despite of a few exceptions, body organs which are served by ANS re-
ceive fibers from both sympathetic and parasympathetic divisions. As seen in 
Figure 3, the automaticity of sinus is controlled by two branches of autonomic 
nervous system. To keep the body system running smoothly, counterbalancing 
each other activity, sympathetic and parasympathetic divisions serve the same 
organ but essentially cause opposite effects[28]. 
 
Figure 3.    Effect of the autonomic nervous system on the ionic currents and 
resulting changes of sinus automaticity, E = epinephrine; NE = norepinephrine; 
Ach = acetylcholine; Ica = calcium current; If = hyperpolarisation-activated 
“pacemaker” current; IKAch = potassium current . Taken from [44] 
 
2.2.1 Sympathetic Nervous System 
Sympathetic Nervous System (SNS) is vastly active when our body is excited 
by stimulus. SNS regulates flight and fight responses. Basically, it makes us 
ready for strenuous physical activity. When we face emergency or threatening 
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situation then SNS prepares the body for that situation. Deep and rapid breath-
ing, fast heartbeat, dilated eye pupils are the sure sign of sympathetic activity. 
Under those conditions, heart rate, blood pressure and blood glucose levels are 
increased by SNS that help us to cope with those situations.[29] 
 
SNS division is also called thoracolumbar division because its preganglionic 
neurons arise from T1 through L2 of the spinal cord (see Figure 4). These pre-
ganglionic axons are mostly short and synapse with postganglionic neurons 
within ganglia of sympathetic ganglion trunk. The sympathetic ganglion trunk or 
chain lies in parallel along either side of spinal cord. This preganglionic axon 
may synapse with postganglionic neuron at same level or different level from 
which it arise. Interestingly, one preganglionic axon can synapse with several 
postganglionic neurons in many different ganglia.[29] 
 
The long postganglionic axon then extends to the organ it serves.  Or the pre-
ganglionic axon pass through the sympathetic ganglion chain without synapsing 
with postganglionic neurons and form part of the splanchnic nerves. The 
splanchnic nerves travel to viscera for synapsing with postganglionic neurons 
which found in a collateral ganglion. The collateral ganglion is located in the 
halfway between CNS and visceral tissue. It is the celiac and the superior and 
inferior mesenteric ganglia which supply the pelvic and abdominal organs. After 
leaving these collateral ganglion, postganglionic axon travel to the nearby vis-
ceral organ it serves.[28] 
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Figure 4.    Anatomy and physiology of the autonomic nervous system. Taken 
from[28] 
 
2.2.2 Parasympathetic Nervous System 
Parasympathetic nervous system (PNS) works for our rest and peace. Activity 
of this division mostly is active when our body is not threatened and is at rest. It 
is also called resting and digesting division. After taking meal when we take rest 
then it is active and it surly slows down the heart activity. Blood pressure, respir-
atory and heart rates are at normal levels, digesting food is going by digestive 
tract[29].   
 
PNS division is also called craniosacral division because the preganglionic neu-
rons arise from the brain nuclei of several cranial nerves- III, VII, IX and X and 
from S2 through S4 of the spinal cord (see Figure 4). In this division, the axons 
of preganglionic neurons are longer than preganglionic axons of sympathetic 
system. These preganglionic axons synapse with postganglionic neurons within 
terminal ganglion which is closed to or embedded within the organs they serve. 
The axons of postganglionic neurons are short. Cranial nerves send their axon 
serving head and neck organs. In a terminal ganglion, preganglionic axon syn-
apse with the ganglionic motor neuron. After synapsing, postganglionic neurons 
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extends towards effector tissue. The preganglionic neurons which arise from sa-
cral region leave spinal cord and form pelvic splanchnic which travel to the pel-
vic cavity. They synapse with postganglionic motor neurons in terminal ganglion 
which is close to or embedded within the organs they serve.[28] 
2.2.3 Comparison Between Sympathetic and Parasympathetic 
Distinguishing features of these two different parts of ANS are listed in Table 1. 
Table 1.    Distinctive characteristics of the sympathetic and parasympathetic 
system 
 
 
 
 
 
 
 
 
 
 
Sympathetic System Parasympathetic system 
originates from T1 through L2 of the 
spinal cord 
originates from the brain nuclei of 
several cranial nerves- iii, VII, IX and 
X and from S2 through S4 of the spi-
nal cord 
ganglia located in collateral ganglion 
or  sympathetic ganglion trunk 
terminal ganglion is close to or em-
bedded within target tissue 
Ratio of preganglionic fiber to post-
ganglionic fiber is 1:20 
1:1 ratio of  preganglionic fiber to 
postganglionic fiber 
diffuse discharge of activity is possi-
ble at any given moment. 
active on specific organ at any given 
moment  
predominant during emergency and 
exercise 
predominant during not threatened 
and resting condition 
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Sympathetic and parasympathetic both are the part of ANS but they are working 
on organs in opposite with respect to each other. The effects of them on differ-
ent organs are listed in Table 2. 
 
Table 2.    Effects of autonomic nervous system on different organs/systems.  
 
 Organs/Systems Sympathetic effects Parasympathetic ef-
fects 
Eye(iris) Dilated pupils Constricted pupils 
Eye(ciliary muscle) Relaxation for distance 
vision 
Contraction for close vi-
sion 
Heart HR, rate of conduction 
and force of contraction 
increase  
HR and rate of conduc-
tion decrease 
Digestive system decreasing secretion by 
digestive system glands; 
constricted sphincters 
Increasing mobility of 
smooth muscle and se-
cretion by digestive sys-
tem glands; relaxed 
sphincters 
Liver Released glucose to 
blood 
No effect 
Lungs Dilated bronchioles Constricted bronchioles 
Kidney Decreased urine output No effect 
Glands-salivary, lacri-
mal, gastric 
Inhabits  stimulates 
Adrenal medulla Increased secretion of 
epinephrine, norepi-
nephrine  
No effect 
Sweat glands of skin Produced perspiration No effect 
Arrector pili muscle Produced goose bumps No effect 
Penis Ejaculation  Erection 
Cellular metabolism Metabolic rate increased No effect 
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2.3 Heart Rate Variability 
The complex and constantly changing oscillations of heart allow the cardiovas-
cular system to rapidly adjust sudden  physical and physiological challenges to 
homeostasis[40].  
 
The heart is constantly regulated by ANS to meet life's demands, result-
ing in time variations between each heartbeat. The variation between two con-
secutive heartbeat is described by HRV. It is universally accepted as a non-in-
vasive marker of operation on the ANS.[8] 
 
It is a predictor of long-term survival after acute myocardial infarction (AMI). De-
creased HRV can be an indicator of severe coronary artery disease, heart fail-
ure, aging and diabetic neuropathy. Whereas increased HRV is a sign of good 
functional heart .[18] 
 
The control of HR includes both sympathetic and parasympathetic branches of 
the ANS. The activity of the SNS increases HR and reduces HRV, while the ac-
tivity of the PNS decreases HR and increases HRV[1]. Autonomous perfor-
mance control includes many interconnected areas of the central nervous sys-
tem, which form the so-called central autonomic network. Arterial baroreceptor 
reflex as well as respiration are known to cause rapid changes in heart rate in 
addition to this central control. The baroreflex is based on baroreceptors that 
are mounted on the walls of some large vessels and can feel the stretching of 
the walls of the vessels caused by increased pressure. Both sympathetic and 
parasympathetic activity is affected by the stimulation of baroreceptors via a 
common baroreflex arc (see Figure 5). Typically, the most conspicuous oscilla-
tory component of HRV is respiratory sinus arrhythmia (RSA), in which the stim-
ulation of the vagus nerve is cut off during inhalation, and therefore HR in-
creases during inhalation and decreases during exhalation. This HRV portion of 
high frequency (HF) is thus based at respiratory frequency and is considered to 
range from 0.15 to 0.4 Hz. Another important feature of HRV is the component 
of low frequency (LF) varying from 0.04 to 0.15 Hz. The HF component is medi-
ated almost exclusively by PNS activity, whereas the LF component is mediated 
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by SNS and PNS activity as well as by baroreflex activity[1],[6]. However, the 
origin of the LF oscillations is regarded as dominated by SNS and the normal-
ized power of the LF component could be used to evaluate sympathetic efferent 
activity[34],[10]. In contrast, the fluctuations below 0.04 Hz were not studied as 
much as the higher frequencies. These frequencies are usually split into very 
low frequency (VLF, 0.003-0.04 Hz) and ultra low frequency (ULF, 0-0.003 Hz) 
bands, but the ULF band is generally omitted in the case of short-term record-
ings[6] . Such lowest frequency rhythms are descriptive of HRV signals and 
were related to, for example, humoral influences such as thermoregulatory pro-
cesses and the renin-angiotensin system[1].  
 
Heart rate variability is a commonly used tool when attempting to evaluate the 
functioning of autonomic cardiac regulation. It has been used as an indirect in-
strument for assessing the functioning and equilibrium of the autonomic nervous 
system (ANS) in multiple studies related to cardiovascular science and various 
applications of human well-being.[22] 
 
Figure 5.    Functioning of the baroreflex arc. Taken from[22] 
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2.3.1 Problems with HRV Measurement  
The detection of HRV changes over a period of hours or days requires the col-
lection and analysis of a large volume of ECG data. Traditionally this has been 
done with Holter devices that record the ECG in outpatients over periods of 24 h 
to several weeks. Due to the relative infrequency of such events, data capture 
on dynamic changes in HRV in the timeframe before arrhythmias or ischaemic 
events is more difficult to attain. Signal quality and elimination of background ‘ 
noise ‘ when analyzing HRV is critical. It is particularly difficult to interpret HRV 
in patients who are not in the rhythm of the sinus (e.g. atrial fibrillation) or those 
with highly irregular HR or numerous ventricle ectopic (VE) beats. Most HRV 
studies exclude patients who are not in the rhythm of the sinus but there is con-
troversy about multiple VEs. Some authors support the exclusion of signals con-
taining more than 10 ectopic beats per hour[19].  
 
If evaluating a signal with ectopic beats, most writers suggest eliminating and 
correcting the ectopic beats for them by changing the R wave peak position and 
putting a beat between the two adjacent beats at midway. A final problem when 
calculating HRV is to locate the consecutive R-wave peaks on the ECG with ac-
curacy. That needs a robust algorithm for the R-wave detector. The more pre-
cise the R-wave detector, the less error in the HRV spectrum analyzed. A totally 
skipped R wave can cause more error than a marginally mis-corrected R wave, 
and this error is more expressed in the high frequency power (HFP) than low 
frequency power (LFP) in the HRV spectrum.[37] 
2.3.2 QRS Detection and Beat Detection 
The purpose of the study of heart rate variability is to analyze the rhythm of the 
sinus modulated by the autonomic nervous system. Therefore, the occurrence 
times of the SA-node action potentials should be technically detected which ini-
tiate each heartbeat. However this is not feasible in practical applications. Alter-
natively, an electrocardiogram (ECG) is registered by placing two or more elec-
trodes on skin contact, and the ECG measures heart beats. The P-wave arising 
from atrial depolarization is the nearest detectable phenomenon in the ECG as 
opposed to SA-node firing (see Figure 6). Nevertheless, the P-wave’s signal-to-
noise ratio is clearly lower than that of the strong QRS complex which primarily 
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results from ventricular depolarization. Therefore, the duration of heart beat is 
generally measured as the time difference between the easily detectable QRS 
complexes. A typical QRS detector is a preprocessing component which is fol-
lowed by a decision rule. In recent decades numerous QRS detectors have 
been proposed[48],[9],[12],[35]. 
 
 
 
Figure 6.    Cardiac electrophysiology. Taken from[22] 
 
 
2.3.3 Measurement Principle And Analysis Methods of HRV 
Variation has long been known in the time interval between consecutive R wave 
peaks of the QRS complex. Measurement of this RR interval is used to deter-
mine variation in heart rate[17].  
 
HRV is measurable in time or in frequency domains. Methods in the time do-
main are the easiest to execute. In the ECG trace, each N (or R) point is de-
fined, and variables such as mean HR and measured the longest and shortest 
N-N intervals. Analysis of the time domain is a general measure of the autono-
mous nervous system balance and is based on altered versions of the standard 
heart rate deviation calculation, defined in terms of the R-R sinus intervals over 
time. Frequency domain analysis uses either autoregressive (AR) or fast Fou-
rier transform (FFT) techniques to delineate parasympathetic (high-frequency 
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components) from sympathetic (low-frequency components) of autonomic con-
trol. These measure how the ECG signal variance (or power) changes as a fre-
quency function.[37],[4] 
Considering the complex heart control systems it is reasonable to assume that 
the heart rate regulation involves nonlinear mechanisms. Analyzing the nonlin-
ear properties of HRV, the Poincaré plot, recurrence plot, approximate and 
sample entropy are measured commonly. The number of studies using such 
methods has substantially increased in the last few years. However, the down-
side of those methods is still the difficulty of the results being interpreted physio-
logically.[22] 
2.3.4 Heart Rate Variability Parameters 
There are a lot more parameters for HRV. Many of them, however, are redun-
dant. There are six widely used time domain measurements: SDANN, 24-hr SD, 
SD, RMSSD, RR50, and% RR50[4] . HRV time-domain parameters calculate 
the sum of interbeat interval (IBI) measurement variability which is the period 
between successive heartbeats (see Table 3). These values can be expressed 
in the original units or as the natural logarithm (Ln) of the original units to obtain 
a more normal distribution[45]. 
Table 3.    HRV time domain parameters. Modified from[40]  
 
Parameter Unit Description 
SDNN ms Standard deviation of 
NN intervals 
SDRR ms Standard deviation of 
RR intervals 
SDANN ms Standard deviation of 
the average NN inter-
vals for each 5 min seg-
ment of a 24 h HRV re-
cording 
SDNN index (SDNNI) ms Mean of the standard 
deviations of all the NN 
intervals for each 5 min 
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segment of a 24 h HRV 
recording 
pNN50 % Percentage of succes-
sive RR intervals that 
differ by more than 
50 ms 
HR Max − HR Min bpm Average difference be-
tween the highest and 
lowest heart rates dur-
ing each respiratory cy-
cle 
RMSSD ms Root mean square of 
successive RR interval 
differences 
HRV triangular index  Integral of the density of 
the RR interval histo-
gram divided by its 
height 
TINN ms Baseline width of the 
RR interval histogram 
 
Measurements of the Frequency Domain estimate the distribution of absolute or 
relative power into four frequency bands. The Task Force of the European Soci-
ety of Cardiology and the North American Society of Pacing and Electrophysiol-
ogy (1996) divided heart rate (HR) oscillations into ultra-low-frequency (ULF), 
very-low-frequency (VLF), low-frequency (LF), and high-frequency (HF) bands 
(see Table 4). 
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Table 4.    HRV frequency domain parameters. Modified from[40] 
 
Parameter Unit Description 
ULF power ms2 Absolute power of the 
ultra-low-frequency 
band (≤0.003 Hz) 
VLF power ms2 Absolute power of the 
very-low-frequency 
band (0.0033–0.04 Hz) 
LF peak Hz Peak frequency of the 
low-frequency band 
(0.04–0.15 Hz) 
LF power ms2 Absolute power of the 
low-frequency band 
(0.04–0.15 Hz) 
LF power nu Relative power of the 
low-frequency band 
(0.04–0.15 Hz) in nor-
mal units 
LF power % Relative power of the 
low-frequency band 
(0.04–0.15 Hz) 
HF peak Hz Peak frequency of the 
high-frequency band 
(0.15–0.4 Hz) 
HF power ms2 Absolute power of the 
high-frequency band 
(0.15–0.4 Hz) 
HF power nu Relative power of the 
high-frequency band 
(0.15–0.4 Hz) in normal 
units 
  
18 
HF power % Relative power of the 
high-frequency band 
(0.15–0.4 Hz) 
LF/HF % Ratio of LF-to-HF power 
 
Power is the energy of a signal found within a frequency band. Measurements 
of frequency-domains can be expressed in absolute or relative power. Absolute 
power is measured as ms squared divided by cycles (ms2/Hz) per second. Rel-
ative power is estimated as the percentage of total HRV power or in normal 
units (nu), dividing the absolute power for a specific frequency band by the sum 
of the absolute power of the LF and HF bands. This allows us to compare two 
customers ' frequency-domain measurements directly, despite wide variation in 
specific band power and total power among healthy, age-matched people.[24] 
The ULF band (average 0.003 Hz) indexes IBI variations between 5 min and 24 
h and is measured using 24 h recordings[20]. 
 
The VLF band (0.0033–0.04 Hz) contains rhythms with intervals varying from 25 
to 300 s. The LF band (0.04–0.15 Hz) consists of rhythms with periods between 
7 and 25 s and is affected by ~3 to 9 bpm respiration. Within a sample of 5 min, 
there are 12–45 complete periods of oscillation[24]. Breathing from 9 to 24 bpm 
influences the HF or respiratory band (0.15–0.40 Hz)[14]. Under controlled con-
ditions, the ratio of LF to HF power (LF / HF ratio) can estimate the relationship 
between sympathetic nervous system (SNS) activity and parasympathetic nerv-
ous system (PNS). Total power is the sum of energy in the ULF, VLF, LF, and 
HF bands for 24 hours and in the VLF, LF, and HF bands for short-term record-
ing[41]. 
 
Non linear measurements allow us to quantify the unpredictability of a time se-
ries[43]. 
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Table 5.    Non linear HRV parameters. Modified from[40] 
 
Parameter Unit Description 
S ms Area of the ellipse which 
represents total HRV 
SD1 ms Poincaré plot standard 
deviation perpendicular 
the line of identity 
SD2 ms Poincaré plot standard 
deviation along the line 
of identity 
SD1/SD2 % Ratio of SD1-to-SD2 
ApEn  Approximate entropy, 
which measures the 
regularity and complex-
ity of a time series 
SampEn  Sample entropy, which 
measures the regularity 
and complexity of a time 
series 
DFA α1  Detrended fluctuation 
analysis, which de-
scribes short-term fluc-
tuations 
DFA α2  Detrended fluctuation 
analysis, which de-
scribes long-term fluctu-
ations 
D2  Correlation dimension, 
which estimates the 
minimum number of var-
iables required to con-
struct a model of system 
dynamics 
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PNS activity or vagal stimulation which decrease the HR or increase the mean 
RR interval and increase HRV. The HF component of HRV is mainly based on 
the efferent vagal stimulation. The root mean square of successive RR interval 
(RMSSD) reflects the higher frequency fluctuation of HRV.[46] 
 
SNS activity which increase HR or decrease mean RR interval and decrease 
HRV. The LF component of HRV is considered to both parasympathetic and 
sympathetic activities. However, probably sympathetic activity  is more domi-
nant component. HF power normalised unit (n.u) has a direct link to parasympa-
thetic activity and LF power normalised unit (n.u) has a direct link to sympa-
thetic activity. In Kubios HRV, PNS index is computed based on mean RR, 
RMSSD and HF power (n.u.). SNS index is computed based on mean HR, 
Baevsky’s stress index and LF power (n.u.). The values of these parameters 
are compared to their normal values and computed as mean deviation from 
their normal values. In summary, PNS and SNS indexes give reliable estimates 
of parasympathetic and sympathetic activities of ANS as compared to normal 
resting values.[46] 
2.4 HRV is More Than The ANS 
HRV was also known to be a surrogate parameter of the complex brain-cardio-
vascular relationship. According some newer theories, HRV reflects as much 
the state of the heart as the state of the brain. The neurovisceral integra-
tion model suggests that the cardiac vagal tone, defined as HF-in-
dex in HRV among others, may mirror the functional balance of the neural net-
works involved in interactions between emotion and cognition.  
 
The sinoatrial node, respiratory system, endocrinological system, immunological 
system, metabolic function and some other physiological systems with Influence 
on HRV can be reflected by HRV. HRV is more than an indicator of ANS and it 
has some significances on some other physiological systems.[7] 
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2.5 Effect of Open Chest Surgery to HRV 
Lung surgery has in the past included a big open operation, known as thoracot-
omy. This approach involves making a large incision and spreading the ribs 
apart with retractors, in order to gain access to the lungs. With new technologi-
cal advances, lung surgery can now be done via a less invasive technique, 
called "Minimally Invasive Pulmonary Resection"[13]. 
 
There are several risk scores for mortality in cardiac surgery. All of these in-
clude a significant number of independent risk factors. The operative mortality in 
elective cardiac surgery patients is small, the number of events reported per 
year is limited, and the risk model may be overfitted[36]. Autonomic function af-
ter myocardial infarction has been shown to be a strong predictor of cardiac 
mortality[25]. Currently, HRV is primarily used in routine clinical practice for risk 
stratification of occurrence of malignant arrhythmia, and sudden death in pa-
tients with myocardial infarction (MI)[30]. Previous studies showed that HRV de-
creases significantly after coronary artery bypass grafting (CABG), even more 
distinctly than in patients with MI[23]. In addition, in clinical practice a large 
number of patients with an implanted artificial valve were found to have de-
creased HRV in the first few months following cardiac valve surgery[31]. 
 
In relevant literature there are practically no significant studies which analyzed 
HRV after cardiothoracic surgery. Therefore, the purpose of this study is that 
the understanding of recovery phase through HRV immediately after cardiotho-
racic surgery. 
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3. MATERIALS AND METHODS 
The patient’s ECG signals were measured at Tampere University Hospital, Fin-
land. The patients were mainly divided into two types of surgery patients. Tho-
racic surgery includes cardiac surgery and pulmonary surgery, these two types 
of patient’s ECG data was extracted by the author. The patients have different 
histories and conditions, therefore some basic medical information of patients 
are discussed. The author measured the RR intervals for those ECG signals. 
Those RR intervals were used to measure the HRV parameters of those pa-
tients. The statistical analysis was performed by the author for evaluation of re-
covery phase of those patients.   
 
3.1 Materials 
Between May and June 2013, a pilot study consisted of 12 patients was meas-
ured. The study’s second phase began in September 2013 and concluded in 
Spring 2016. The hospital recruited a total of 136 patients from elective sched-
uled cardiothoracic surgery. The patient’s participation was voluntary and fo-
cused on informed consent. The institutional ethics committee of the Pirkanmaa 
Hospital District, Finland approved the study. 
 
The author only analysed the ECG signal. The descriptive characteristics of pa-
tients are presented from Milla Jauhiainen’s master of science thesis[16] in Ta-
ble 6. 
Table 6.    Descriptive characteristics of patients and some of the measure-
ments were not measured duo to some complications. 
 
Variable Value(Mean ± SD)   Study Population(N) 
Age (Years) 63.4 ± 12.8  136 
Gender(male/female) 84/52 136 
Weight (Kg) 81.0 ± 16.8  132 
Smoking 25 136 
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The study population’s age was varied from 18 to 79 years. There were three 
different groups based on their surgery type. Cardiac surgery patients (C), mi-
nor pulmonary surgery patients (PM) and pulmonary surgery patients with re-
section (PR) were these three groups. Different types of open heart surgeries 
were included in group C. A surgical biopsy was performed in PM and PM sur-
gery was done by using either video-assisted thoracoscopic surgery 
(VARTS) or thoracotomy. In PR, the complete lung or a portion of lung was re-
moved and PR surgery also was done by either VARTS or thoracotomy. 
Two equally sized intervention groups were created by randomizing patients 
from these three surgery. These intervention groups were created based on the 
physiotherapy they got. Positive expiratory pressure physiotherapy (PEP-P) for 
control group (A)  and inspiratory muscle training physiotherapy (IMT-P) for con-
trol group (B). Whereas every other physiotherapies were same for them. 
All those physiotherapies and measurements were done amongst normal hospi-
tal routines of the patient. Duo to the study, the processing of care and nursing 
were not affected or prolonged. The measurements were performed one day 
before the surgery (PREOP) and 1-3 days after the surgery (1POP, 2POP and 
3POP respectively). 3POP was measured only in surgery group C. 
3.2 Measurement Procedure 
The measurements usually were done in one session but some of them were 
done in two separate sessions.  The measurements were measured by a physi-
otherapist along with other routines of hospital. The procedure of measure-
ments were same for before operation and for 1-3 days after the operation. 
However, the execution of procedure was effected by patient’s condition after 
surgery.  
 
In PREOP, after the measurement, physiotherapy with PEP-P and IMT-
P was given to evaluate the patients ' true baseline before any respiratory train-
ing. Physiotherapy was provided in postoperative measurements be-
fore the measurement. The measurement procedure is clearly described in Milla 
Jauhiainen’s master’s thesis[16]. 
  
24 
3.3 Measurement Devices 
ECG was measured by a portable device (see Figure 7). The device was similar 
one that descried by Vuorela et al.[49]. 256 Hz was the sampling frequency of 
ECG. Two electrodes were used to measure the ECG. At the height of fifth in-
tercostal space, two electrodes were placed in the midaxillary line and other two 
electrodes are placed in the opposite to the first two electrodes. Firstly, data 
was stored in the device memory and then after each measurement it was 
transferred to a computer. 
 
       
Figure 7.    Device is for impedance pneumography, measuring bioimpedance 
and ECG simultaneously (left) and tetrapolar electrode configuration (right). 
Four commonly used electrodes are attached to the skin. Blue electrodes are 
used for driving a small alternating current to the body and red electrodes 
measure the resulting voltage. Sketch on the right modified from[16] 
 
Two available devices were used to collect data. One device of the two availa-
ble devices measured ECG data. Two devices were similar but the AD trans-
ducer’s reading might vary between devices. One is used for the patients 
throughout the measurement if it works properly otherwise other device was 
used. 
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3.4 Signal Processing 
The ECG signal was processed with MATLAB R2015b software. The R peaks 
were detected by using detection algorithm of Sergey Chernenko[26]. The sig-
nal processing flow for measuring RR interval is presented in Figure 8. 
 
 
 
 
 
Figure 8.    ECG signal processing scheme for measuring RR interval.  
 
The main task of ECG signal processing was RR interval calculation. The 10 
minutes ECG raw signal was selected for measuring RR interval. The 10 
minutes was selected based on the restful state of patients. The start and end 
indices of ECG signal were selected by Milla Jauhiainen[16]. The signal pro-
cessing for detecting R peaks is illustrated in Figure 9. As the ECG is uneven. 
So the first step was to straighten ECG signal. To do that, direct fast Fourier 
transform-FFT was used removing low frequencies. Then, inverse FFT was 
used for restoring ECG. After that, windowed filter was used to find local max-
ima. Windowed filter took only maximum values in its window and ignores all 
other values. Window of default size was used in this step. For removing small 
values and taking only significant ones, a threshold filter was used. For getting 
ECG raw 
data
Convert FFT
Inverse FFT 
Windowed 
filter
Threshold 
filter
R peak
Visual 
check
RR interval
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all the peaks, window size adjusted and repeated filtering. Then visually 
checked the results. A few measurements did not need repeated filtering. 
 
 
 
 
 
Figure 9.    MATLAB figures of Signal processing steps of a random measure-
ment for detecting R peaks. The first 15 seconds of 10 minutes measurement is 
taken for showing the steps clearly. 
 
 
 
 
 
 
 
 
 
 
 
The calculated RR intervals were in millisecond. The RR intervals were saved 
as a text file for each measurement. These text files were used as input in soft-
ware Kubios. 
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3.5 Kubios HRV Parameters  
The RR intervals were used as input in Kubios HRV standard 3.1.0. Software 
kubios HRV standard analysed RR intervals and gave HRV parameters of re-
spective measurement. Kubios HRV standard was used as an extractor of the 
HRV parameters for each measurement. The PNS index is computed from 
Mean RR (ms), RMSSD (ms) and SD1 (%); and SNS index is from Mean HR 
(bpm), Baevsky’s stress index and SD2 (%)[22]. All parameters with unit and 
description is presented in Table 7. 
Table 7.    Summary of the HRV parameters from the HRV Analysis Software 
Kubios with descriptions. Taken from[22] 
 
PARAMETER UNIT DESCRIPTION 
Overview 
  
PNS index – Parasympathetic nervous system activity compared 
to normal resting values 
SNS index – Sympathetic nervous system activity compared to 
normal resting values 
HR zones [%] Time spent in Maximum, Hard, Moderate, Light, Very 
light, and Inactive HR zones 
Stress zones [%] Time spent in Very high, High, Elevated, Normal, and 
Low stress levels 
RMSSD zones [%] Time spent in Very low, Low, Lowered, Normal, and 
High RMSSD levels 
Energy exp. [kcal/min
] 
Energy expenditure is divided into Basal Metabolic 
Rate (BMR) and activity related energy expenditure. 
BMR is estimated with Mifflin-St Jeor formula and en-
ergy expenditure (EE) using Keytel’s model  
TRIMP [TRIMP/
min] 
Training impulse (TRIMP) is estimated using the ex-
ponential Banister’s model 
Time Domain 
  
𝑅𝑅 
 
[ms] The mean of RR intervals 
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STD RR 
(SDNN) 
[ms] Standard deviation of RR intervals 
𝐻𝑅 
 
[beats/mi
n] 
The mean heart rate 
Min & Max HR [beats/mi
n] 
Minimum and maximum HR computed using N beat 
moving average (default value: N=5) 
RMSSD [ms] Square root of the mean squared differences be-
tween successive RR intervals 
NNxx [beats] Number of successive RR interval pairs that differ 
more than xx ms (default value: xx=50) 
pNNxx [%] NNxx divided by the total number of RR intervals 
HRV triangular 
index 
– The integral of the RR interval histogram divided by 
the height of the histogram 
TINN [ms] Baseline width of the RR interval histogram 
Stress index – Square root of Baevsky’s stress index 
SDANN [ms] Standard deviation of the averages of RR intervals in 
5-min segments 
SDNNI [ms] Mean of the standard deviations of RR intervals in 5-
min segments 
Frequency-Do-
main 
  
Spectrum 
 
Welch’s (or Lomb-Scargle) periodogram and AR 
spectrum estimates 
Peak frequency [Hz] VLF, LF, and HF band peak frequencies 
Absolute power [ms2] Absolute powers of VLF, LF, and HF bands 
Absolute power [log] Natural logarithm transformed values of absolute 
powers of VLF, LF, and HF bands 
Relative power [%] Relative powers of VLF, LF, and HF bands: 
VLF [%] = VLF [ms2] / total power [ms2] x 100% 
LF [%] = LF [ms2] / total power [ms2] x 100% 
HF [%] = HF [ms2] / total power [ms2] x 100% 
Normalized 
power 
[n.u.] Powers of LF and HF bands in normalised units: 
LF [n.u.] = LF [ms2] / (total power [ms2] – VLF [ms2]) x 
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100% 
HF [n.u.] = HF [ms2] / (total power [ms2] – VLF [ms2]) 
x 100% 
LF/HF – Ratio between LF and HF band powers 
EDR [Hz] ECG derived respiration (available only if ECG data is 
used for HRV analysis) 
Nonlinear 
  
SD1 [ms] In Poincaré plot, the standard deviation perpendicular 
to the line-of-identity   
SD2 [ms] In Poincaré plot, the standard deviation along the 
line-of-identity 
SD2/SD1 – Ratio between SD2 and SD1 
ApEn – Approximate entropy  
SampEn – Sample entropy 
DFA, α1 – In detrended fluctuation analysis, short term fluctua-
tion slope  
DFA, α2 – In detrended fluctuation analysis, long term fluctua-
tion slope 
D2 – Correlation dimension  
RPA 
 
Recurrence plot analysis  
  Lmean [beats] Mean line length 
  Lmax [beats] Maximum line length 
  REC [%] Recurrence rate 
  DET [%] Determinism 
  ShanEn – Shannon entropy 
MSE – Multiscale entropy for scale factor values τ=1,2,…,20   
 
3.6 Statistical Analysis of HRV Parameters 
The HRV parameters were statistically analysed by software environment R. 
The normality of each HRV parameter out of 53 HRV parameters for 
PREOP, 1POP, 2POP and 3POP measurement was checked by using Shapiro-
Wilk test. Student’s paired t-test (or sometimes called Student’s dependent t-
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test) was used for normally distributed data. Wilcoxon signed-rank test was 
used for non-normally distributed data. The student’s paired t-test and Wilcoxon 
signed-rank test were perform among in all groups of patients. Those tests were 
also performed among in patients group PM, PR and C. Those tests compared 
each HRV parameter of PREOP measurement with the same each HRV param-
eter of 1POP, 2POP and 3POP measurement respectively. Those tests also 
compared HRV parameters of 1POP measurement  with HRV parameters of 
2POP and 3POP measurement. The comparison of HRV parameters between 
2POP and 3POP measurement was also performed. In the patient groups, com-
parison of HRV parameters of 2POP and 3POP measurement  was done only 
for C group.  
 
Student unpaired t-test and Wilcoxon sum rank test were performed  in between 
control group A and B of all surgery groups. These tests were also performed 
inside the individual patient surgery group. Firstly, the difference of every 
HRV parameters between two measurement days of one intervention group 
were measured and then the difference between two measurement days of 
every HRV parameters of other intervention group were measured and finally 
performed these statistical tests between two intervention groups with differ-
ence of same measurement days. Example, The statistical tests were per-
formed between difference of PREOP and 1POP of intervention group A and 
difference of PREOP and 1POP. Of course, before performing statistical text 
the normality of each difference was checked. 
 
The p values of those tests presented with corresponding mean ± SD values for 
some specific HRV parameters. PNS and SNS indexes provide reliable esti-
mates of autonomic nervous system activities. The selected HRV parameters 
for presenting results are PNS index, SNS index, STD RR, RMSSD, Alpha 1, 
LF [n.u.] and HF [n.u.]. However, all HRV parameters are presented in appen-
dix. 
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4. RESULTS 
4.1 Measurement Results of RR Interval  
 
  
 
Figure 10.    Chart of included and excluded measurements of the patients in 
the signal processing. 
 
If the QRS detection algorithm detected 95% of R-peaks then RR interval was 
measured. If it was less than 95% then the measurement was excluded from 
study. Only the measurements with 95% R-peaks detection were included for 
measuring RR interval.  
 
In total of 136 patient’s ECG signal were planned to analysis but 3 of them were 
missing duo to unsuccessful measurement. Another 3 patients had no post-op-
erative measurement. Some of them did not have 1POP measurements. Some 
of them did not have 2POP and only heart surgery group (C) had 3POP meas-
urement. Duo to unsuccessful (95%) R-peak detection, some measurements 
were excluded from study (see Figure 10).  
  
•123 
measurements;
•10  excluded
•46 
measurements;
•11excluded
•125 measurem
ents;
•14 excluded
•133 measurem
ents; 
•11 excluded
PREOP 1POP
2POP3POP
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4.2 Statistical Tests for All Surgery Group 
Table 8.    PNS index, SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and 
HF [n.u.] are presented as mean ± SD for all surgery group on comparison be-
tween different measurement days. Student paired t-test for normally distributed 
data and Wilcoxon signed rank test for not normally distributed data between 
different measurement days of all surgery groups. 
 
Parameter Comparison  
            Mean ± SD  
 
p value 
 
 
PNS index PREOP vs 1POP 0.69±2.43 0.42±2.34 0.2418 
PREOP vs 2POP 0.76±2.69 0.27±2.35 0.0258 
PREOP vs 3POP 1.54±3.3 0.85±2.59 0.1477 
1POP vs 2POP 0.32±2.15 0.2±2.32 0.5773 
1POP vs 3POP 0.71±2.67 0.83±2.68 0.7816 
2POP vs 3POP 0.62±2.02 0.68±2.24 0.8242 
SNS index PREOP vs 1POP 0.46±1.75 1.12±2.32 0.0083 
PREOP vs 2POP 0.43±1.73 1.44±2.37 0.00001 
PREOP vs 3POP 0.12±1.84 1.11±2.27 0.0224 
1POP vs 2POP 1.17±2.34 1.55±2.4 0.1188 
1POP vs 3POP 1.18±2.7 1.22±2.41 0.9396 
2POP vs 3POP 1.07±2.34 1.11±2.27 0.9108 
STD RR PREOP vs 1POP 48.51±49.45 38.9±44.44 0.0236 
PREOP vs 2POP 49.65±53.9 40.79±47.96 0.0600 
PREOP vs 3POP 64.67±69.54 56.7±53.67 0.4125 
1POP vs 2POP 36.46±40.23 39.77±47.57 0.4643 
1POP vs 3POP 42.79±48.88 55.23±55.21 0.1767 
2POP vs 3POP 43.72±42.66 53.34±49.92 0.2724 
RMSSD PREOP vs 1POP 63.12±75.75 53.68±71 0.1419 
PREOP vs 2POP 64.88±83.84 54.95±72.9 0.1492 
PREOP vs 3POP 87.21±107.95 80.75±79.05 0.6603 
1POP vs 2POP 49.84±65.11 53.3±71.9 0.6245 
1POP vs 3POP 63.18±80.53 78.33±81 0.3039 
2POP vs 3POP 62.95±65.68 75.15±71.15 0.2752 
Alpha 1 PREOP vs 1POP 0.89±0.32 0.78±0.34 0.0023 
PREOP vs 2POP 0.88±0.32 0.85±0.38 0.3386 
PREOP vs 3POP 0.82±0.29 0.68±0.28 0.0341 
1POP vs 2POP 0.79±0.34 0.85±0.39 0.0754 
1POP vs 3POP 0.69±0.37 0.69±0.3 0.8148 
2POP vs 3POP 0.7±0.37 0.67±0.27 0.9615 
LF [n.u.] PREOP vs 1POP 50.87±22 45.67±24.08 0.0309 
PREOP vs 2POP 51.14±21.22 45.81±25.02 0.0177 
PREOP vs 3POP 46.94±20.75 40.79±20.36 0.1535 
1POP vs 2POP 45.98±24.22 46.49±25.16 0.8376 
1POP vs 3POP 41.09±26.03 40.77±21.58 0.9587 
2POP vs 3POP 31.8±22.74 41.05±20.71 0.0090 
HF [n.u.] PREOP vs 1POP 48.92±21.86 54.04±23.88 0.0313 
PREOP vs 2POP 48.66±21.09 53.88±24.82 0.0185 
  
33 
PREOP vs 3POP 52.85±20.63 58.81±20.15 0.1584 
1POP vs 2POP 53.74±24.03 53.2±24.96 0.8293 
1POP vs 3POP 58.57±25.81 58.86±21.37 0.9617 
2POP vs 3POP 67.72±22.51 58.56±20.5 0.0089 
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative, 
3POP = 3. post-operative measurement 
 
 
The student paired t-test or Wilcoxon signed rank test shows (see Table 8) that 
there was significant difference in the selected parameters between 
PREOP and 1POP except PNS index and RMSSD. For SNS index, The statisti-
cal test shows that there was significant difference between PREOP and 1-3 
post-operative measurement days. The significant level (p-value) was less than 
0.05. 
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4.3 Statistical Tests in Different Surgery Group 
4.3.1  Statistical Tests for Surgery Group C 
 
Table 9.    PNS index, SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and 
HF [n.u.] are presented as mean ± SD for surgery group C on comparison be-
tween different measurement days. Student paired t-test for normally distributed 
data and Wilcoxon signed rank test for not normally distributed data between 
different measurement days of surgery group C. 
 
Parameter Comparison  
      Mean ± SD  
 
p value 
 
 
PNS index PREOP vs 1POP 1.92±3.19 0.67±2.63 0.0356  
PREOP vs 2POP 2.17±3.64 0.8±2.79 0.0185  
PREOP vs 3POP 1.8±3.32 0.79±2.65 0.0347  
1POP vs 2POP 0.45±2.15 0.64±2.72 0.9197  
1POP vs 3POP 0.67±2.79 0.75±2.75 0.8633  
2POP vs 3POP 0.53±2.07 0.6±2.27 0.9019  
SNS index PREOP vs 1POP -0.16±1.82 1.16±2.61 0.0226  
PREOP vs 2POP -0.18±1.84 1.1±2.44 0.0099  
PREOP vs 3POP -0.08±1.78 1.23±2.32 0.0029  
1POP vs 2POP 1.32±2.65 1.22±2.52 0.8417  
1POP vs 3POP 1.38±2.77 1.38±2.48 0.9962  
2POP vs 3POP 1.14±2.45 1.25±2.33 0.739  
STD RR PREOP vs 1POP 70.72±69.37 43.05±48.43 0.0214  
PREOP vs 2POP 76.53±77.9 48.42±55.72 0.0303  
PREOP vs 3POP 69.72±70.69 56.08±54.17 0.1626  
1POP vs 2POP 38.99±37.53 44.31±52.83 0.6491  
1POP vs 3POP 42.93±51.43 54.28±55.96 0.2536  
2POP vs 3POP 41.88±42.08 52.26±50.03 0.2069  
RMSSD PREOP vs 1POP 97.15±105.63 63.9±79.18 0.0627  
PREOP vs 2POP 105.59±120.91 70.97±89.51 0.079  
PREOP vs 3POP 94.15±110.46 79.65±80.02 0.3317  
1POP vs 2POP 57.84±65.69 65.06±85.36 0.7147  
1POP vs 3POP 63.63±84.32 76.71±82.34 0.4196  
2POP vs 3POP 59.99±64.87 73.3±71.33 0.2757  
Alpha 1 PREOP vs 1POP 0.79±0.31 0.7±0.35 0.2899  
PREOP vs 2POP 0.78±0.32 0.7±0.37 0.4319  
PREOP vs 3POP 0.81±0.3 0.7±0.28 0.1064  
1POP vs 2POP 0.72±0.35 0.7±0.38 0.438  
1POP vs 3POP 0.7±0.38 0.71±0.31 0.7265  
2POP vs 3POP 0.72±0.39 0.69±0.27 0.9911  
LF [n.u.] PREOP vs 1POP 44.64±21.63 42.25±24.54 0.6219  
PREOP vs 2POP 44.92±21.55 33.75±23.77 0.0358  
PREOP vs 3POP 46.95±21.34 42.01±20.85 0.2699  
1POP vs 2POP 43.28±25.16 34.87±24.06 0.1782  
1POP vs 3POP 42.65±26.46 42.26±22.29 0.671  
  
35 
2POP vs 3POP 32.67±23.59 42.46±21.28 0.0156  
HF [n.u.] PREOP vs 1POP 55.15±21.5 57.4±24.37 0.6219  
PREOP vs 2POP 54.89±21.44 65.76±23.56 0.0358  
PREOP vs 3POP 52.85±21.21 57.61±20.64 0.2781  
1POP vs 2POP 56.41±25.04 64.65±23.87 0.1782  
1POP vs 3POP 57.03±26.27 57.38±22.07 0.7078  
2POP vs 3POP 66.83±23.34 57.16±21.06 0.0156  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative, 
3POP = 3. post-operative measurement 
 
 
In particular, student paired t-test or Wilcoxon signed rank test shows (see Ta-
ble 9) that there were significant differences between PREOP and measure-
ment days 1-3 post-operative measurement days of the SNS index and PNS in-
dex. The significant level (p-value) was less than 0.05. 
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4.3.2 Statistical Tests for Surgery Group PR 
 
Table 10.    PNS index, SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and 
HF [n.u.] are presented as mean ± SD for surgery group PR on comparison be-
tween different measurement days. Student paired t-test for normally distributed 
data and Wilcoxon signed rank test for not normally distributed data between 
different measurement days of surgery group PR. 
Parameter Comparison          
        Mean ± SD 
p value 
 
 
PNS index PREOP vs 1POP 0.25±1.63 0.07±1.65 0.3574  
PREOP vs 2POP 0.11±1.59 -0.15±1.78 0.4051  
1POP vs 2POP 0.04±1.62 -0.1±1.82 0.4321  
SNS index PREOP vs 1POP 0.58±1.5 1.6±2.4 0.0429  
PREOP vs 2POP 0.65±1.55 1.97±2.42 0.002  
1POP vs 2POP 1.57±2.46 2.01±2.48 0.3451  
STD RR PREOP vs 1POP 39.13±33.42 32.94±33.96 0.1944  
PREOP vs 2POP 35.61±30.14 33.29±40.54 0.7217  
1POP vs 2POP 30.92±31.17 33.92±41.55 0.651  
RMSSD PREOP vs 1POP 48.77±49.1 43.76±49.94 0.4797  
PREOP vs 2POP 44±44.7 43±56 0.911  
1POP vs 2POP 40.78±45.67 43.84±57.38 0.7314  
Alpha 1 PREOP vs 1POP 0.89±0.3 0.8±0.36 0.1941  
PREOP vs 2POP 0.9±0.31 0.88±0.39 0.8522  
1POP vs 2POP 0.8±0.36 0.87±0.4 0.1433  
LF [n.u.] PREOP vs 1POP 51.08±22.33 47.29±25.17 0.5563  
PREOP vs 2POP 51.8±22.26 50.06±25.85 0.6462  
1POP vs 2POP 46.85±25.39 49.76±26.21 0.414  
HF [n.u.] PREOP vs 1POP 48.66±22.18 52.4±24.95 0.566  
PREOP vs 2POP 47.94±22.11 49.69±25.67 0.6566  
1POP vs 2POP 52.84±25.16 49.97±26.03 0.423  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative 
 
 
 
The Student paired t-test or Wilcoxon signed rank test shows (see Table 10) that 
there was no significant difference in the selected HRV parameters between meas-
urement days. The significant level (p-value) was less than 0.05. 
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4.3.3 Statistical Tests for Surgery Group PM 
 
Table 11.    PNS index, SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and 
HF [n.u.] are presented as mean ± SD for surgery group PM on comparison be-
tween different measurement days. Student paired t-test for normally distributed 
data and Wilcoxon signed rank test for not normally distributed data between 
different measurement days of surgery group PM. 
Parameter Comparison          
        Mean ± SD 
p value 
 
 
PNS index PREOP vs 1POP 0.17±2.09 0.56±2.64 0.1658  
PREOP vs 2POP 0.28±2.28 0.25±2.41 0.9167  
1POP vs 2POP 0.47±2.56 0.17±2.42 0.3168  
SNS index PREOP vs 1POP 0.82±1.83 0.67±1.95 0.5645  
PREOP vs 2POP 0.68±1.72 1.23±2.26 0.184  
1POP vs 2POP 0.71±1.94 1.37±2.24 0.0393  
STD RR PREOP vs 1POP 40.61±38.89 41.22±49.9 0.9088  
PREOP vs 2POP 42.06±40.98 41.73±47.94 0.9498  
1POP vs 2POP 39.69±48.82 41.84±49.43 0.7311  
RMSSD PREOP vs 1POP 50.97±61.94 55.12±80.71 0.6307  
PREOP vs 2POP 53.03±66.28 53.59±71.88 0.9379  
1POP vs 2POP 52.4±78.8 53.58±73.97 0.9026  
Alpha 1 PREOP vs 1POP 0.95±0.33 0.83±0.31 0.0025  
PREOP vs 2POP 0.95±0.32 0.93±0.35 0.3285  
1POP vs 2POP 0.83±0.31 0.94±0.36 0.0396  
LF [n.u.] PREOP vs 1POP 55.28±21.37 46.71±23.04 0.0147  
PREOP vs 2POP 55.17±19.37 51.04±22.56 0.0947  
1POP vs 2POP 47.09±22.92 51.69±22.8 0.1922  
HF [n.u.] PREOP vs 1POP 44.55±21.23 53.03±22.83 0.0153  
PREOP vs 2POP 44.67±19.22 48.75±22.41 0.0947  
1POP vs 2POP 52.67±22.72 48.1±22.65 0.1876  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative 
 
 
The Student paired t-test or Wilcoxon signed rank test shows (see Table 11) 
that there was significant difference in the selected HRV parameters (Alpha 1 
and LF [n.u.] and HF [n.u.]) between PREOP and 1POP. The Student paired t-
test or Wilcoxon signed rank test shows that there was no significant difference 
in the selected HRV parameters between other measurement comparisons ex-
cept 1POP vs 2POP of PNS index. The significant level (p-value) was less than 
0.05. 
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4.4 Statistical Tests for Two Different Intervention Groups 
4.4.1 Intervention Groups of All Surgery Groups 
 
Table 12.    Difference between different measurement days, PNS index, 
SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and HF [n.u.] are presented as 
mean ± SD for different intervention group. Student unpaired t-test for normally 
distributed data and Wilcoxon rank sum test for not normally distributed data be-
tween different intervention groups (A & B). 
 
Parame-
ter 
Difference and 
comparison  
                           Mean ± SD p value 
 
 
            A                 B 
 
 
PNS in-
dex 
PREOP & 1POP 0.52±2.41 0.01±2.25 0.3499  
PREOP & 2POP 0.69±2.28 0.28±2.28 0.3434  
PREOP & 3POP 0.84±3.37 0.52±1.89 0.9999  
1POP & 2POP 0.01±1.79 0.22±2.37 0.624  
1POP & 3POP -0.48±2.62 0.33±1.78 0.3079  
2POP & 3POP -0.43±2.01 0.32±1.37 0.2475  
 
 
SNS in-
dex 
PREOP & 1POP -0.7±2.63 -0.61±2.55 0.5222  
PREOP & 2POP -1.11±2.41 -0.92±2.41 0.7499  
PREOP & 3POP -0.78±1.83 -1.24±3.06 0.9349  
1POP & 2POP -0.43±2.9 -0.32±1.85 0.7061  
1POP & 3POP 0.3±2.81 -0.44±1.95 0.2875  
2POP & 3POP 0.12±1.91 -0.2±1.62 0.7701  
STD RR PREOP & 1POP 15.71±47.06 3.63±40.56 0.1507  
PREOP & 2POP 15.53±48.68 2.32±50.04 0.1577  
PREOP & 3POP 11.93±69.14 3.25±39.12 0.6588  
1POP & 2POP -3.62±39.69 -2.97±51.91 0.9432  
1POP & 3POP -19.34±58.98 -3.93±30.94 0.3744  
2POP & 3POP -21.29±48.54 2.83±26.96 0.1294  
RMSSD PREOP & 1POP 17.55±70.36 1.46±63.55 0.2091  
PREOP & 2POP 17.59±72.67 2.4±72.5 0.2682  
PREOP & 3POP 12.01±107.37 -0.14±54.01 0.8831  
1POP & 2POP -5.11±65.03 -1.74±78.89 0.8131  
1POP & 3POP -24.6±97.87 -3.52±43.88 0.3744  
2POP & 3POP -28.08±73 4.74±41.21 0.1294  
Alpha 1 PREOP & 1POP 0.13±0.28 0.08±0.34 0.4363  
PREOP & 2POP 0.08±0.36 -0.01±0.4 0.3478  
PREOP & 3POP 0.18±0.34 0.09±0.37 0.5021  
1POP & 2POP -0.05±0.32 -0.07±0.36 0.656  
1POP & 3POP 0.03±0.51 -0.04±0.48 0.9141  
2POP & 3POP 0.03±0.51 0.02±0.39 0.8001  
LF [n.u.] PREOP & 1POP 3.23±24.82 7.15±24.66 0.2871  
PREOP & 2POP 5.63±24.26 5.02±26.97 0.763  
PREOP & 3POP 4.67±27.03 7.92±25.4 0.8318  
1POP & 2POP 1.29±24.54 -2.39±26.5 0.3166  
1POP & 3POP -0.16±33.83 0.92±33.73 0.846  
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2POP & 3POP -9.14±18.73 -9.37±18.78 0.8609  
HF [n.u.] PREOP & 1POP -3.19±24.67 -7.01±24.47 0.3146  
PREOP & 2POP -5.51±24.1 -4.92±26.77 0.763  
PREOP & 3POP -4.45±26.89 -7.76±25.19 0.8318  
1POP & 2POP -1.21±24.42 2.36±26.3 0.3166  
1POP & 3POP 0.23±33.61 -0.94±33.13 0.846  
2POP & 3POP 9.11±18.55 9.2±18.5 0.8609  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative 
 
The Student unpaired t-test or Wilcoxon rank sum test shows (see Table 12)  
that there was no significant difference in the selected HRV parameters be-
tween measurement days. The significant level (p-value) was less than 0.05. 
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4.4.2 Intervention Groups of Surgery Group C 
 
Table 13.    Difference between different measurement days, PNS index, 
SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and HF [n.u.] are presented as 
mean ± SD for different intervention group. Student unpaired t-test for normally 
distributed data and Wilcoxon rank sum test for not normally distributed data be-
tween different intervention groups (A & B). 
 
Parame-
ter 
Difference and 
comparison  
                           Mean ± SD p value 
 
 
            A                 B 
 
 
PNS in-
dex 
PREOP & 1POP 1.07±3.83 1.43±2.35 0.6539  
PREOP & 2POP 1.94±3.19 0.8±3.04 0.3414  
PREOP & 3POP 1.01±3.39 1.03±1.09 0.8368  
1POP & 2POP 0.2±2.2 -0.64±3.62 0.6177  
1POP & 3POP -0.42±2.7 0.38±1.91 0.3842  
2POP & 3POP -0.36±2.05 0.26±1.39 0.3389  
 
 
SNS in-
dex 
PREOP & 1POP -0.98±3.6 -1.68±2.42 0.7405  
PREOP & 2POP -1.17±2.48 -1.38±2.83 0.926  
PREOP & 3POP -0.95±1.7 -1.77±2.9 0.6395  
1POP & 2POP 0.01±3.06 0.2±2.23 0.9639  
1POP & 3POP 0.25±2.9 -0.34±2.12 0.443  
2POP & 3POP -0.04±1.86 -0.19±1.7 0.9639  
STD RR PREOP & 1POP 28.28±77.81 27.01±46.25 1  
PREOP & 2POP 45.48±68.36 10.74±69.4 0.2388  
PREOP & 3POP 13.94±70.57 13.25±20.69 0.7788  
1POP & 2POP 4.69±53.06 -16.88±69.89 0.586  
1POP & 3POP -19.7±61.04 0.01±26.09 0.3565  
2POP & 3POP -21.27±50.24 2.17±28.24 0.2352  
RMSSD PREOP & 1POP 30.44±116.65 36.26±71.09 0.5717  
PREOP & 2POP 58.64±107.71 10.61±105.81 0.3809  
PREOP & 3POP 15.06±109.63 13.76±27.63 1  
1POP & 2POP 9.69±93.82 -26.74±114.15 0.3701  
1POP & 3POP -24.11±101.28 1.97±41.4 0.3565  
2POP & 3POP -27.21±75.48 2.74±42.96 0.2539  
Alpha 1 PREOP & 1POP 0.17±0.38 0.01±0.39 0.2995  
PREOP & 2POP 0.17±0.51 -0.01±0.47 0.2703  
PREOP & 3POP 0.16±0.34 0.05±0.38 0.3772  
1POP & 2POP -0.01±0.34 0.06±0.45 0.7856  
1POP & 3POP 0±0.51 -0.03±0.5 0.9188  
2POP & 3POP 0.01±0.51 0.05±0.42 0.8562  
LF [n.u.] PREOP & 1POP 3.5±25.77 1.2±31.44 0.9224  
PREOP & 2POP 11.26±30.51 11.09±30 0.9556  
PREOP & 3POP 3.68±27.46 6.56±26.14 0.8368  
1POP & 2POP 6.42±28.21 10.7±33.62 0.4672  
1POP & 3POP -1.84±34.32 3.44±35.98 0.8384  
2POP & 3POP -10.65±18.34 -8.81±20.01 0.8207  
HF [n.u.] PREOP & 1POP -3.36±25.63 -1.07±31.11 0.9845  
  
41 
PREOP & 2POP -10.92±30.39 -10.81±29.62 0.9556  
PREOP & 3POP -3.45±27.3 -6.44±25.95 0.8368  
1POP & 2POP -6.26±28.11 -10.51±33.37 0.5551  
1POP & 3POP 1.9±34.1 -3.43±35.35 0.8384  
2POP & 3POP 10.6±18.18 8.6±19.71 0.8207  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative 
 
 
The Student unpaired t-test or Wilcoxon rank sum test shows (see Table 13) 
that there was no significant difference in the selected HRV parameters be-
tween measurement days. The significant level (p-value) was less than 0.05. 
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4.4.3 Intervention Groups of Surgery Group PR 
 
Table 14.    Difference between different measurement days, PNS index, 
SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and HF [n.u.] are presented as 
mean ± SD for different intervention group. Student unpaired t-test for normally 
distributed data and Wilcoxon rank sum test for not normally distributed data be-
tween different intervention groups (A & B). 
 
Parameters Difference and 
Comparison 
                   
               Mean ± SD 
p value 
 
 
     A     B 
PNS index PREOP & 1POP 0.4±1.09 -0.03±2.32 0.3854  
PREOP & 2POP 0.22±1.51 0.29±2.24 0.8175  
1POP & 2POP -0.14±1.01 0.42±1.79 0.2562  
SNS index PREOP & 1POP -0.76±2.62 -1.27±3.01 0.84  
PREOP & 2POP -1.1±2.79 -1.54±2.12 0.3249  
1POP & 2POP -0.46±3.36 -0.41±2.04 0.9378  
STD RR PREOP & 1POP 10±19.35 2.37±36.14 0.5635  
PREOP & 2POP 5.58±21.14 -0.95±52.81 0.3249  
1POP & 2POP -3.85±22.72 -2.16±51.91 0.9875  
RMSSD PREOP & 1POP 11.05±27.4 -1.03±54.96 0.6235  
PREOP & 2POP 2.94±38.36 -0.94±68.31 0.8304  
1POP & 2POP -7.59±38.23 1.47±65.5 0.6161  
Alpha 1 PREOP & 1POP 0.1±0.28 0.08±0.37 0.6861  
PREOP & 2POP 0.06±0.36 -0.03±0.42 0.6441  
1POP & 2POP -0.03±0.33 -0.12±0.32 0.5212  
LF [n.u.] PREOP & 1POP 1.26±24.35 6.31±22.31 0.4879  
PREOP & 2POP 4.19±25.64 -0.7±28.94 0.7729  
1POP & 2POP 1.09±13.75 -6.9±19.63 0.1341  
HF [n.u.] PREOP & 1POP -1.29±24.17 -6.2±22.12 0.5063  
PREOP & 2POP -4.16±25.4 0.66±28.81 0.7729  
1POP & 2POP -1.02±13.57 6.76±19.48 0.1427  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative 
 
The Student unpaired t-test or Wilcoxon rank sum test shows (see Table 14) 
that there was no significant difference in the selected HRV parameters be-
tween measurement days. The significant level (p-value) was less than 0.05. 
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4.4.4 Intervention Groups of Surgery Group PM 
 
Table 15.     Difference between different measurement days, PNS index, 
SNS index, STD RR, RMSSD, Alpha 1, LF [n.u.] and HF [n.u.] are presented as 
mean ± SD for different intervention group. Student unpaired t-test for normally 
distributed data and Wilcoxon rank sum test for not normally distributed data be-
tween different intervention groups (A & B). 
 
Parameters Difference and 
Comparison 
                Mean ± SD P value 
  
 
A B 
PNS index PREOP & 1POP 0.18±1.85 -0.92±1.64 0.05  
PREOP & 2POP 0.16±1.69 -0.1±1.63 0.4626  
1POP & 2POP 0.01±2.06 0.59±1.71 0.3416  
SNS index PREOP & 1POP -0.43±1.68 0.67±1.54 0.0302  
PREOP & 2POP -1.08±2.08 -0.04±2.13 0.2043  
1POP & 2POP -0.72±2.41 -0.58±1.37 0.5831  
STD RR PREOP & 1POP 11.07±31.18 -11.22±33.76 0.0318  
PREOP & 2POP 1.7±39.98 -0.99±27.78 0.8003  
1POP & 2POP -9.65±41.01 5.34±37.26 0.234  
RMSSD PREOP & 1POP 13.42±49.16 -20.11±57.1 0.0476  
PREOP & 2POP -0.43±51.03 -0.69±44.14 0.9855  
1POP & 2POP -
13.98±59.33 11.61±60.7 0.1855  
Alpha 1 PREOP & 1POP 0.12±0.21 0.13±0.29 0.7365  
PREOP & 2POP 0.03±0.19 0±0.35 0.9329  
1POP & 2POP -0.09±0.29 -0.12±0.33 0.7584  
LF [n.u.] PREOP & 1POP 4.87±25.66 11.92±21.39 0.3487  
PREOP & 2POP 2.65±17.1 5.55±22.84 0.3286  
1POP & 2POP -2.37±29.28 -6.83±25.13 0.4777  
HF [n.u.] PREOP & 1POP -4.87±25.51 -11.76±21.32 0.3487  
PREOP & 2POP -2.62±17.05 -5.47±22.77 0.3408  
1POP & 2POP 2.39±29.17 6.75±25.01 0.4777  
*PREOP = preoperative, 1POP = 1. postoperative, 2POP = 2. Postoperative 
 
The Student unpaired t-test or Wilcoxon rank sum test shows (see Table 15)  
that there was no significant difference in the selected HRV parameters be-
tween measurement days except comparison pair PREOP and 1POP of 
SNS index, STD RR and RMSSD. The significant level (p-value) was less than 
0.05. 
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5. DISCUSSION 
The clinicians acknowledged ECG measurement, and it was simple to perform 
the measurement procedure among normal patient care. Just a few patients 
had refused to take part in the study. Since the entire study protocol included a 
30-minute IP and spirometry measurement session, other individual assess-
ments, and regular physiotherapy lessons, coordination between the schedules 
of the patient and physiotherapist has been challenging from time to time. 
 
The results and further effectiveness of this study are discussed. Some errors 
and difficulties are also discussed. The results including all HRV parameters are 
presented in appendix. 
5.1 Effective RR Interval Measurement 
The QRS detection algorithm could not detect QRS complex 100% accurately. 
Some of the measurements were excluded from the study because the algo-
rithm did not detect R peaks correctly. If 95% of R-peaks were observed by the 
QRS identification algorithm then RR intervals were measured. The measure-
ments were excluded from the study if it was less than 95%. Only measure-
ments with detection of 95% R-peaks were included in this study to measure 
the RR interval.  
 
The detection accuracy was visually checked and it was time consuming. How-
ever, It was important to see that most of the R peaks of a measurement were 
detected correctly. 10-11% of the measurements were excluded from study duo 
to less than 95% detection of R peaks. There might be several reasons for that 
poor detection. ECG signals might be too noisy for detecting right R peaks as 
well as the algorithm filter was not working correctly with those signals. Some 
other algorithms might be useful in those cases but those signals had very irreg-
ular R peaks.  Depending on the signal availability and quality, a few measure-
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ments were excluded from the study before using QRS detection algorithm. Be-
cause those signals were distorted, noisy and some measurements did not 
have post-operative days measurements. 
5.2 Error Origins in Measurement Setup 
The study was conducted between normal hospital practices, so redoing the 
measurements or testing the ECG records was not usually possible. Addition-
ally, if the measurement device was not functioning correctly, an expert was not 
qualified to repair it immediately. In measurement of this study, the electrode 
configuration was followed according Seppä et al.[39]. Młyńczak et al.[32] re-
ported that the electrode configuration validated by Seppä et al.[39] is suitable 
under static conditions, but the configuration should be less prone to motion ar-
tefacts for ambulatory measurements. 
 
ECGs contaminated by artefacts or noise conflict the normal functioning of the 
automatic analysis algorithm[21]. Motion artefacts were one of the most fre-
quent explanations in the study for excluding a measurement. This was already 
done at study start when all ECG signals were visually checked. If the patient 
shifted rapidly the ECG signal was very skewed and there was no regular 
RR interval present at all. This triggered rapid changes in signal amplitude in 
the ECG, a continuous signal of zero amplitude and a gradual decrease in the 
waveform of the ECG signals. Unable to interpret these signals. 
 
Motion artefacts are part of the transient change of baseline caused by the 
movements of the electrode which are the result of movement of a sub-
ject. There are several experiments using the filtered or differential approach to 
minimize motion artefacts.[27] 
 
When improving the measurement setup these signal errors should be carefully 
considered. More detailed explanations for the errors should be identified. To 
determine if the cause was due to the behaviour of the researcher or patient, 
and if the errors could be avoided in further tests. 
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5.3 Statistical Analysis 
The comparison between different measurement days was selected depending 
on the distribution of HRV parameters. When the HRV parameters of both days 
were normally distributed then, the student paired t test was used. Whereas, 
Wilcoxn signed rank test was performed between different measurement days. 
Student paired t test and Wilcoxon signed rank test are used for dependent 
samples. In this study,  PREOP and 1POP,2POP,3POP  were dependent sam-
ples because same patient has PREOP measurement and post operational 
measurements.  
 
The t-test was used to determine if the means of different days of HRV parame-
ters were significantly different from each other. The results showed that some 
of the parameters are significantly different from different measurement days. 
The results showed that in surgery group C, PNS index and SNS index are sig-
nificantly different from PREOP to 1-3 POP. In other surgery groups, significant 
difference was not consistently observed. Most possibly, this is due to minimally 
invasive procedure of thoracic surgery. 
 
5.4 The Effect of Intervention 
All patients were randomized into two subgroups: control group (A) and study 
group (B). Both groups received different physiotherapy interventions: group A 
received traditional expiration-focused PEP-P physiotherapy and group B re-
ceived inspiration-focused IMT-P. No significant differences were found in 
HRV parameters except surgery group PM. The results showed that the HRV 
parameters were not significantly different for different measurement days. 
 
The preliminary randomized controlled clinical study shows that when the respi-
ration is tested using spirometry, there is a significant difference in recovery be-
tween intervention approaches in cardiac patients. However, intervention ap-
proaches did not have significant effect in this study. In surgery group PM, there 
were some selected HRV parameters (see table 15) have significant differences 
between PREOP and 1POP. 
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5.5 HRV in Evaluation of Recovery Phase  
The recovery phase could not be identified with this study. Most possibly, this is 
because of the only 2-3 days’ timeframe tracked. The reported recovery of auto-
nomic function was linked to an observation period of 12 weeks[2]. The results 
published by Soares et al.[42] support this theory by identifying a decrease in 
autonomic function immediately following coronary artery surgery which is most 
distinct 6 days after surgery.  
 
Since the surgery groups PM and PR not directly affect the heart hence signifi-
cant differences of HRV parameters between different measurement days were 
not consistently observed. The main objective of an improved recovery program 
following thoracic surgery is to minimize stress response, reduce postoperative 
pulmonary complications and improve patient outcomes, which will also de-
crease hospital stay and lower hospital costs. Video-assisted thoracoscopic sur-
gery as a minimally invasive procedure represents an important part of an im-
proved recovery program in thoracic surgery[5].  
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6. CONCLUSION 
For use of appropriate methods in HRV analysis, the actual physiological effect 
on variability in RR intervals and in HR should be studied more precisely. The 
effects of various cardiac and neural diseases on HRV are not widely studied, 
and the use of RR intervals in large numbers of HRV studies has shown that 
variations in RR intervals have important prognostic value in the cardiac mortal-
ity.  
 
The effect of cardiothoracic surgery to the HRV is difficult to generalize. The pa-
tients perioperatively had different diagnoses and general conditions, and the 
success during the tests relied on the patient's actual condition as well as the 
subjective perception of the pain or the orientation-effecting drugs. 
 
It has been shown that open chest surgery is not only associated with a reduc-
tion in autonomic cardiovascular activity, but that there is a strong relationship 
between the type of surgery and its effects on the cardiovascular variability. In 
particular, PR and PM surgery showed to be beneficial in terms of maintaining 
autonomic activities compared to surgery group C. For Minimally invasive tho-
racic surgery or some other reasons, the significant differences were not con-
sistently found in surgery group PR and PM. Depending on the types of cardiac 
surgeries, it can be studied in further.  
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APPENDIX A: RESULTS OF INTERVENTION FOR ALL GROUPS 
 
 
Results of interventions for all surgery group including all HRV parameters: 
 
 
Parameters                                                                                                                                                        Mean ± SD 
                                                                   A                                                                  B 
01 02 03 12 13 23 01 02 03 12 13 23 
PNS.index 0.52±2.41 0.69±2.28 0.84±3.37 0.01±1.79 -0.48±2.62 -0.43±2.01 0.01±2.25 0.28±2.28 0.52±1.89 0.22±2.37 0.33±1.78 0.32±1.37 
SNS.index -0.7±2.63 -1.11±2.41 -0.78±1.83 -0.43±2.9 0.3±2.81 0.12±1.91 -0.61±2.55 -0.92±2.41 -1.24±3.06 -0.32±1.85 -0.44±1.95 -0.2±1.62 
Stress.index -4.28±13.61 -5.71±12.65 -0.29±5.5 -
1.68±17.9
1 
4.01±15.53 4.38±9.33 -
4.15±11.6
8 
-
4.27±12.0
7 
-
4.14±14.8
3 
-0.15±9.4 0.31±8.21 -0.43±8.4 
Mean.RR...ms
. 
24.94±165.5 74.74±156.1 136.31±295.
77 
39.45±113
.18 
38.15±234.
09 
30.25±200.
68 
25.43±158
.97 
71.33±142
.1 
152.39±17
0.29 
48.87±96.1
2 
99.27±153
.96 
2.25±103.
58 
STD.RR..ms. 15.71±47.06 15.53±48.68 11.93±69.14 -
3.62±39.6
9 
-
19.34±58.9
8 
-
21.29±48.5
4 
3.63±40.5
6 
2.32±50.0
4 
3.25±39.1
2 
-2.97±51.91 -
3.93±30.9
4 
2.83±26.9
6 
Mean.HR..bea
ts.min. 
-1.68±12.75 -5.44±11.63 -
13.08±24.05 
-
3.05±11.5
5 
-5.09±22.35 -5.99±16.37 -
1.86±12.8
2 
-
5.68±11.7
7 
-
12.03±14.
26 
-3.99±8.57 -
8.06±13.4
7 
0.86±10.6 
STD.HR..beat
s.min. 
1.19±5.06 0.62±4.52 -2.68±7.86 -0.34±6.61 -3.64±14.09 -4.26±9.78 -0.01±3.65 -0.88±5.49 -0.73±3.96 -0.94±6.46 -1.32±3.82 1.29±3.44 
Min.HR..beats
.min. 
-3.66±12.94 -6.56±12.18 -9.62±19.16 -2.59±9.52 -1.72±12.2 -1.39±11.27 -
2.95±13.0
8 
-5.6±11.54 -
10.13±14.
57 
-2.72±8.16 -
4.41±10.3
6 
0.33±10.9
6 
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Max.HR..beat
s.min. 
1.81±16.77 -2.18±16.05 -
13.02±31.66 
-
3.15±19.5
5 
-8.43±38.21 -10.2±26.29 -
1.76±16.1
2 
-
6.32±17.2
7 
-
13.74±15.
33 
-5.1±17.79 -
10.71±17.
07 
2.37±11.2
9 
RMSSD..ms. 17.55±70.36 17.59±72.67 12.01±107.3
7 
-
5.11±65.0
3 
-24.6±97.87 -28.08±73 1.46±63.5
5 
2.4±72.5 -
0.14±54.0
1 
-1.74±78.89 -
3.52±43.8
8 
4.74±41.2
1 
NNxx..beats. 21.07±132.7
6 
7.55±187.71 -
45.47±274.2
1 
-
12.32±226
.73 
-
75.38±408.
27 
-
149.62±280
.02 
15.3±134.
9 
-
1.82±128.
13 
-
23.81±178
.27 
-
9.98±142.9
1 
-
41.54±178
.06 
7.87±51.1
1 
pNNxx.... 4.69±18.73 3.23±26.12 1.1±29.47 -
2.26±23.9
9 
-8.66±40.18 -
15.94±28.2
6 
2.62±21 1.07±17.3 -
0.99±23.6
7 
-0.11±18.36 -2.1±20.54 0.22±5.6 
RR.tri.index 1.75±8.55 2.16±8.8 2.25±11.36 -0.32±5.52 -1.93±13.23 -5.1±8.73 2.23±6.49 1.48±6.97 1.63±9.2 -0.64±4.41 -1.97±7.05 0.3±2.22 
TINN..ms. 106.31±377.
71 
117.55±351.
08 
50.95±446.2
6 
1.92±301.
67 
-
96.25±429.
89 
-
128.81±310
.96 
33.25±287
.33 
44.67±322
.03 
-
11.06±255
.51 
16.45±290.
56 
-
33.08±148
.54 
22.47±310
.84 
SD1..ms. 12.42±49.8 12.45±51.43 8.51±75.99 -
3.61±46.0
1 
-
17.41±69.2
4 
-
19.87±51.6
5 
1.03±44.9
7 
1.7±51.31 -
0.09±38.2
1 
-1.23±55.82 -
2.49±31.0
5 
3.35±29.1
6 
SD2..ms. 18.78±48.13 17.89±47.67 14.23±63.62 -4.07±33.4 -
23.59±49.6
7 
-
22.71±46.6
2 
6.1±36.88 2.86±49.8
1 
5.92±40.7
4 
-4.56±48.89 -
6.14±33.3
8 
1.97±25.1
9 
SD2.SD1.ratio 0.18±0.57 0.05±0.77 0.34±0.51 -0.17±0.71 0.1±0.71 0.17±0.96 0.09±0.63 -0.08±0.94 0.02±0.88 -0.17±0.82 -0.06±0.96 -0.04±0.53 
Approxi-
mate.en-
tropy..ApEn. 
-0.03±0.47 0.04±0.44 0.07±0.59 0.05±0.5 -0.1±0.59 -0.17±0.58 0.07±0.34 0.04±0.41 0.07±0.35 -0.03±0.45 -0.07±0.45 -0.01±0.51 
Sample.en-
tropy..SampE
n. 
-0.04±0.72 0.07±0.72 0.17±0.85 0.09±0.76 -0.01±0.86 -0.21±0.82 0.13±0.57 0.09±0.68 0.18±0.59 -0.01±0.69 -0.12±0.69 -0.04±0.7 
alpha.1 0.13±0.28 0.08±0.36 0.18±0.34 -0.05±0.32 0.03±0.51 0.03±0.51 0.08±0.34 -0.01±0.4 0.09±0.37 -0.07±0.36 -0.04±0.48 0.02±0.39 
alpha.2 -0.01±0.19 -0.05±0.18 -0.03±0.17 -0.04±0.18 0±0.22 0.04±0.18 -0.05±0.22 -0.06±0.18 -0.1±0.28 -0.02±0.19 -0.09±0.31 -0.04±0.19 
VLF..Hz..FFT. 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0 
VLF..Hz..AR. 0±0.02 0±0.02 0±0.01 0±0.02 0±0.02 0±0.02 0±0.01 0.01±0.02 0.01±0.02 0±0.02 0.01±0.02 0±0.02 
LF..Hz..FFT. 0.01±0.04 0.01±0.04 0.01±0.05 0±0.03 -0.01±0.04 -0.01±0.06 0±0.04 0±0.04 0±0.04 0±0.04 0.01±0.05 0±0.05 
LF..Hz..AR. 0±0.04 0.01±0.04 -0.01±0.05 0.01±0.05 -0.01±0.06 -0.02±0.04 0±0.04 0.01±0.05 0±0.06 0.01±0.05 0.01±0.06 0±0.05 
HF..Hz..FFT. -0.01±0.09 -0.03±0.1 -0.06±0.1 -0.02±0.1 -0.02±0.08 0.03±0.09 0±0.08 0±0.07 -0.05±0.08 0±0.08 -0.02±0.1 -0.03±0.08 
HF..Hz..AR. -0.02±0.09 -0.02±0.11 -0.04±0.11 0±0.12 -0.01±0.11 0.03±0.12 -0.01±0.1 0±0.07 -0.01±0.08 0.01±0.09 0.03±0.08 0.01±0.1 
VLF..ms.2..FF
T. 
38.71±153.3
7 
55.92±125.9 16.11±173.7 6.99±117.
19 
-
20.59±169.
32 
-
52.23±121.
98 
35.74±202
.03 
54.09±242
.35 
42.38±190
.77 
3.58±162.4
1 
-
40.5±94.2
5 
-
26.89±50.
8 
VLF..ms.2..AR
. 
105.68±463.
24 
117.24±446.
92 
138.21±689.
78 
-
40.17±303
.14 
-
103.21±579
.76 
-
187.81±473
.31 
22.75±391
.65 
12.46±447
.48 
31.12±156
.63 
-
31.82±309.
32 
-
82.27±184
.2 
-
20.23±110
.12 
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LF..ms.2..FFT
. 
541.1±3222.
64 
913.3±3489.
08 
1101.45±54
30.52 
-
143.82±18
14.95 
-
96.52±3844
.55 
-
1162.61±24
90.48 
303.21±28
23.79 
434.25±26
57.32 
89.02±138
1.24 
-
29.05±1572
.57 
-
477.83±11
41.3 
-
191.41±79
4.22 
LF..ms.2..AR. 625.31±313
6.34 
1013.23±35
21.94 
1850.54±58
43.36 
-
167.36±15
75.51 
-
69.75±3566
.33 
-
960.43±238
2.84 
255.58±32
95.04 
441.15±31
59.47 
359.06±13
38.99 
28.78±1835
.46 
-
342.79±10
06.7 
-
150.3±697
.15 
HF..ms.2..FFT
. 
1457.38±76
75.48 
2178.79±89
40.18 
4096.2±157
57.82 
-
370.77±23
18.88 
-
1429.69±34
88.94 
-
1165.16±44
23.29 
-
75.48±571
4.64 
-
466.12±92
84.19 
-
238.02±21
93.73 
-
989.47±898
7.13 
-
341.05±29
03.87 
-
37.57±804
.43 
HF..ms.2..AR. 1565.08±77
63.49 
2081.51±81
91.02 
3795.74±14
151.56 
-
416.27±23
39.11 
-
1973.62±39
15.81 
-
1460.57±51
54.51 
229.8±602
1.43 
-
256.65±86
49.82 
-
106.9±220
5.06 
-
875.5±7688
.66 
-
324.79±28
46.62 
-
102.1±104
1.82 
VLF..log..FFT. 0.75±2.05 0.83±1.83 0.37±2.08 0.01±1.91 -0.42±2.22 -0.55±1.54 0.62±1.63 0.52±1.58 0.49±1.85 -0.12±1.44 -0.72±1.87 -0.55±1.13 
VLF..log..AR. 0.86±1.97 0.84±2.01 0.43±1.9 -0.08±2.1 -0.64±2.24 -0.68±2.09 0.47±1.56 0.42±1.76 0.48±1.86 -0.03±1.65 -0.61±1.66 -0.17±1.65 
LF..log..FFT. 0.94±2.34 1.12±2.27 0.59±2.53 0.14±2.65 -0.59±2.73 -0.88±2.52 0.69±1.85 0.65±2.02 0.87±2.37 -0.03±1.75 -0.06±1.58 -0.19±1.78 
LF..log..AR. 0.99±2.25 1.1±2.12 0.64±2.22 0.05±2.43 -0.63±2.69 -0.75±2.33 0.75±1.72 0.76±2.17 0.79±2.54 0.03±1.95 -0.11±1.44 -0.14±2.25 
HF..log..FFT. 0.77±2.58 0.87±2.51 0.41±2.88 0.11±2.72 -0.57±2.56 -0.43±2.18 0.34±2.19 0.44±2.37 0.52±2.67 0.16±2.17 -0.01±1.67 0.33±2.15 
HF..log..AR. 0.71±2.4 0.85±2.42 0.05±2.16 0.15±2.56 -0.79±2.7 -0.72±2.22 0.45±2.2 0.63±2.42 0.48±2.64 0.23±2.26 -0.01±1.6 0.08±2.28 
VLF.....FFT. -0.06±11.07 -1.11±10.81 -0.82±10.63 -
1.28±11.6
4 
0.73±10.67 -1.7±8.4 -
1.27±10.3
6 
-
1.65±10.7
1 
-
2.99±12.7
7 
-0.51±10.64 -
2.82±14.7
4 
-4.1±9.76 
VLF.....AR. 0.58±8.99 -0.84±9.3 1.88±7.57 -1.69±9.02 0.76±9.95 0.73±8.46 -2.13±9.19 -2.67±9.22 -
3.47±13.4
8 
-0.5±9.92 -
3.53±19.1
5 
-2.4±8.01 
LF.....FFT. 3.34±20.41 6.25±20.38 4.84±22.28 1.97±19.9
6 
-0.56±28.74 -7.27±18.34 7.75±20.4
2 
6.16±22.0
7 
9.54±18.4
6 
-2.04±21.82 1.47±24.7
4 
-
6.97±14.8
6 
LF.....AR. 4.9±17.76 5.97±19.48 10.7±21.86 -
0.11±18.1
7 
3.63±30.09 -0.54±22.97 6.85±19.1
6 
5.06±20.6
2 
8.71±20.1
7 
-2.15±19.7 -
0.41±20.8
2 
-
3.01±13.5
4 
HF.....FFT. -3.25±24.84 -5.03±24.99 -3.82±27.48 -
0.62±25.2
9 
-0.1±34.23 8.95±19.2 -
6.36±25.6
7 
-
4.43±27.3
8 
-6.4±27.67 2.52±27.14 1.33±36.2
7 
10.89±21 
HF.....AR. -5.4±21.59 -5.01±25.67 -
12.37±26.08 
1.83±23.2
5 
-4.29±37.85 -0.17±28.31 -
4.67±25.0
5 
-2.34±25.4 -
5.13±26.9
9 
2.65±24.91 3.88±37.2 5.35±18.1
8 
LF..n.u...FFT. 3.23±24.82 5.63±24.26 4.67±27.03 1.29±24.5
4 
-0.16±33.83 -9.14±18.73 7.15±24.6
6 
5.02±26.9
7 
7.92±25.4 -2.39±26.5 0.92±33.7
3 
-
9.37±18.7
8 
LF..n.u...AR. 5.59±22.09 5.57±25.57 12.74±25.76 -
1.47±23.0
8 
4.52±37.84 -0.06±28.67 5.84±24.3
3 
3.71±25.9
4 
6.38±27.1
6 
-2.41±24.99 -1.3±33.46 -
4.64±17.7
4 
HF..n.u...FFT. -3.19±24.67 -5.51±24.1 -4.45±26.89 -
1.21±24.4
2 
0.23±33.61 9.11±18.55 -
7.01±24.4
7 
-
4.92±26.7
7 
-
7.76±25.1
9 
2.36±26.3 -
0.94±33.1
3 
9.2±18.5 
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HF..n.u...AR. -5.51±21.95 -5.45±25.46 -
12.52±25.55 
1.5±23 -4.41±37.45 0.08±28.33 -
5.78±24.1
7 
-3.64±25.8 -
6.26±27.0
6 
2.41±24.83 1.24±33.1
3 
4.57±17.5
8 
To-
tal.power..ms.
2..FFT. 
2039.19±10
721.89 
3149.99±12
299.05 
5208.49±20
798.86 
-
509.25±40
19.5 
-
1558.29±70
77.9 
-
2387.39±66
06.2 
260.07±84
54.95 
16.41±115
29.46 
-
106.71±35
68.73 
-
1019.25±99
13.33 
-
866.65±38
42.79 
-
254.22±15
81.19 
To-
tal.power..ms.
2..AR. 
2301.78±11
147.46 
3218.11±11
939.9 
5792±20263
.37 
-
625.14±40
58.62 
-
2163.59±73
49.43 
-
2612.56±76
63.29 
508.66±94
76.58 
194.6±117
49.06 
280.82±35
43.14 
-
882.05±902
3.89 
-
754.59±38
71.53 
-
273.17±17
61.18 
LF.HF.ra-
tio.FFT. 
0.05±3.28 -0.73±7.02 0.08±1.89 -0.87±5.29 0.33±1.91 2.15±10.13 0.05±3.04 -0.6±4.41 0.31±1.3 -0.56±4.75 0.53±1.75 -0.24±0.81 
LF.HF.ra-
tio.AR. 
0.31±2 -0.56±4.79 0.55±1.04 -0.97±4.32 0.38±1.93 1.73±7.89 -0.06±2.09 -0.68±4.34 0.29±1.55 -0.68±4.47 0.51±1.84 -0.09±0.9 
01 means difference between one day before surgery and 1 day after surgery. 02 means difference between one day before sur-
gery and 2 day after surgery, 03 means difference between one day before surgery and 3 day after surgery, 12 means difference 
between 1 day after surgery and 2 day after surgery, 13 means difference between 1 day after surgery and 3 day after surgery and 
23 means difference between 2 day after surgery and 3 day after surgery. Significant differences between different measurement 
days were not found. 
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APPENDIX B: RESULTS OF INTERVENTION FOR DIFFERENT GROUPS 
 
Results of interventions for surgery group C including all HRV parameters: 
 
 
Parameters                                                                                                                                                    Mean ± SD 
                                                                A                                                           B 
01 02 03 12 13 23 01 02 03 12 13 23 
PNS.index 1.07±3.83 1.94±3.19 1.01±3.39 0.2±2.2 -0.42±2.7 -0.36±2.05 1.43±2.35 0.8±3.04 1.03±1.09 -0.64±3.62 0.38±1.91 0.26±1.39 
SNS.index -0.98±3.6 -1.17±2.48 -0.95±1.7 0.01±3.06 0.25±2.9 -0.04±1.86 -1.68±2.42 -1.38±2.83 -1.77±2.9 0.2±2.23 -0.34±2.12 -0.19±1.7 
Stress.index 
-4.48±17.08 -5.5±12.5 -0.81±5.17 -0.7±19.41 4.06±16.07 3.75±9.3 -7.3±10.72 -4.67±14.76 
-
6.38±14.43 2.15±11.12 0.14±8.98 -0.37±9.06 
Mean.RR...m
s. 
74.19±250.
51 
134.9±214.7
4 
151.78±296
.33 
14.87±152
.9 
41.74±241.
85 
34.82±206.
85 
109.32±156
.49 
164.4±127.
87 
178.25±16
3.7 
63.6±101.0
2 89±166.1 
4.49±105.
69 
STD.RR..ms. 
28.28±77.8
1 45.48±68.36 
13.94±70.5
7 
4.69±53.0
6 
-
19.7±61.04 
-
21.27±50.2
4 
27.01±46.2
5 10.74±69.4 
13.25±20.6
9 
-
16.88±69.8
9 
0.01±26.0
9 
2.17±28.2
4 
Mean.HR..be
ats.min. 
-5.73±19.59 -8.62±15.68 
-
14.36±24.0
9 -0.11±17.2 -5.5±23.08 
-
6.54±16.79 -9.07±11.26 
-
14.01±11.0
5 
-
14.52±12.8
7 -5.45±10.2 
-
6.84±14.3
9 
0.69±10.5
9 
STD.HR..beat
s.min. 1±8.48 1.69±6.64 -2.75±8.09 
1.43±11.1
7 
-
3.81±14.57 
-
4.44±10.09 1.56±2.77 -0.57±4.75 0.21±2.12 -2.29±5.49 -0.78±3.32 0.99±3.59 
Min.HR..beat
s.min. 
-7±18.53 -10.13±15.55 
-
10.89±18.8
7 -0.8±10.98 
-
1.86±12.62 
-
1.92±11.46 
-
10.42±10.8
2 
-
12.74±12.3
6 
-
13.39±12.3
3 -3.55±9.22 
-
3.31±10.4
9 
0.56±10.9
6 
Max.HR..beat
s.min. 
-1.71±23.02 -4.24±20.49 
-
14.15±32.1
8 
0.86±28.4
7 -9.2±39.42 
-
10.92±27.0
6 -7.58±12.6 
-
15.82±12.9
6 
-
14.13±14.4
1 -9.31±13.5 
-
8.02±16.4
5 
2.98±11.7
5 
RMSSD..ms. 
30.44±116.
65 
58.64±107.7
1 
15.06±109.
63 
9.69±93.8
2 
-
24.11±101.
28 
-
27.21±75.4
8 
36.26±71.0
9 
10.61±105.
81 
13.76±27.6
3 
-
26.74±114.
15 1.97±41.4 
2.74±42.9
6 
NNxx..beats. 
37.94±226.
36 
91.62±220.2
5 
-
47.83±281.
96 
63.4±312.
89 
-
80.67±422.
03 
-
158.93±28
7.27 
86.13±146.
7 
17.81±125.
09 
16.43±94.4
4 
-
65.54±167.
81 
-
34.73±169
.24 -4.31±40.9 
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pNNxx.... 
10.73±30.7
3 17.01±32.47 1.2±30.32 
4.25±27.8
5 
-
9.28±41.51 
-
16.89±28.9
8 13.9±24.57 5.19±21.02 4.31±13.75 -7.06±22.36 
-
1.75±20.0
3 -0.49±5.62 
RR.tri.index 
5.05±15.3 7.93±11.58 2.48±11.64 0.65±2.87 
-
2.15±13.66 -5.43±8.93 6.88±9.59 4.21±9.95 4.05±4.34 -2.22±6.07 -0.87±4.59 0.46±1.56 
TINN..ms. 
156.69±615
.01 
245.19±458.
47 
71.94±449.
44 
33.4±340.
22 
-
84.4±442.2
7 
-
111.67±31
3.95 
117.13±215
.72 74±377.64 
33.86±229.
71 
-
30.62±288.
93 
-
28.18±160
.17 
13.85±334
.41 
SD1..ms. 
21.55±82.5
6 41.51±76.23 
10.67±77.5
9 
6.86±66.3
8 
-
17.06±71.6
6 
-
19.25±53.4 
25.66±50.3
2 7.51±74.88 9.74±19.55 
-
18.92±80.7
8 1.4±29.3 1.94±30.4 
SD2..ms. 
36.5±79.9 48.2±62.18 
16.01±64.9
8 
-
0.32±35.8
1 
-
24.8±51.17 
-
23.28±48.2 
27.73±43.2
7 
13.47±64.5
2 
16.03±23.5
1 
-
14.52±57.8
7 -1.7±24.31 
2.16±26.4
2 
SD2.SD1.ra-
tio 0.25±0.7 0.17±1.04 0.33±0.53 -0.1±0.81 0.07±0.72 0.14±0.99 -0.02±0.64 0.05±0.78 -0.02±0.94 0.1±0.75 -0.09±1.02 -0.03±0.56 
Approxi-
mate.en-
tropy..ApEn. 0.13±0.69 0.13±0.45 0.06±0.6 -0.01±0.55 -0.12±0.61 -0.2±0.59 0.16±0.39 0.1±0.54 0.09±0.36 -0.04±0.53 -0.03±0.47 -0.01±0.55 
Sample.en-
tropy..SampE
n. 0.19±1.05 0.27±0.79 0.14±0.87 0.05±0.82 -0.05±0.88 -0.28±0.81 0.35±0.71 0.27±0.9 0.24±0.59 -0.01±0.81 -0.07±0.69 -0.04±0.75 
alpha.1 0.17±0.38 0.17±0.51 0.16±0.34 -0.01±0.34 0±0.51 0.01±0.51 0.01±0.39 -0.01±0.47 0.05±0.38 0.06±0.45 -0.03±0.5 0.05±0.42 
alpha.2 -0.04±0.26 -0.11±0.19 -0.04±0.16 -0.07±0.16 -0.01±0.23 0.04±0.18 -0.12±0.22 -0.09±0.21 -0.12±0.28 0.02±0.28 -0.05±0.32 -0.02±0.19 
VLF..Hz..FFT. 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0 0±0 
VLF..Hz..AR. 0±0.02 0±0.02 0±0.02 0±0.02 0±0.02 0±0.02 0±0.02 0±0.02 0.01±0.02 0±0.02 0.01±0.02 0±0.02 
LF..Hz..FFT. 0.02±0.05 0.02±0.05 0.01±0.05 0±0.05 -0.01±0.04 -0.01±0.06 0.01±0.05 0±0.05 0±0.04 0±0.05 0±0.05 0±0.05 
LF..Hz..AR. 0±0.05 0.01±0.05 0±0.05 0.02±0.05 -0.01±0.05 -0.02±0.04 0±0.04 -0.01±0.06 0±0.05 -0.01±0.07 0.01±0.06 0.01±0.06 
HF..Hz..FFT. -0.05±0.11 -0.11±0.08 -0.07±0.1 -0.05±0.11 -0.02±0.08 0.03±0.09 -0.04±0.07 -0.02±0.07 -0.04±0.08 0.01±0.08 0±0.1 -0.02±0.07 
HF..Hz..AR. -0.03±0.11 -0.09±0.09 -0.04±0.11 -0.04±0.13 -0.01±0.12 0.03±0.12 -0.04±0.11 0±0.07 -0.02±0.05 0.01±0.1 0.03±0.08 0±0.09 
VLF..ms.2..F
FT. 43.63±197.
63 
101.11±117.
6 
19.34±178.
15 
15.67±67.
26 
-
23.21±174.
93 
-
53.65±126.
13 
140.75±297
.73 
74.27±283.
57 
65.99±188.
38 
-
64.6±145.7
5 
-
28.18±82.
42 
-
18.68±38.
73 
VLF..ms.2..A
R. 199.12±833
.21 406.82±552 
147.62±708
.53 
26.62±205
.46 
-
111.28±59
9.18 
-
198.12±48
8.06 
240.41±572
.38 
142.26±660
.91 70.66±85.8 
-
105.94±307
.6 
-
59.57±157
.69 
-
13.12±110
.14 
LF..ms.2..FFT
. 877.87±587
3.07 
3160.8±4997
.92 
1170.91±55
79.27 
500.99±14
09.1 
-
105.77±39
79.3 
-
1230.94±2
562.32 
1556.48±48
79.93 
1123.44±41
76.28 
338.99±11
23.43 
-
451.54±122
3.37 
-
306.43±83
6.68 
-
119.3±780
.98 
LF..ms.2..AR. 
1264.9±578
0.26 
3593.48±527
1.74 
1960.99±59
92.32 
382.77±14
78.62 
-
71.82±369
1.49 
-
1017.08±2
455.3 
1738.06±48
47.61 
1595.87±50
10.34 
641.89±10
00.97 
-
235.63±126
6.05 
-
156.81±59
8.67 
-
70.27±659
.1 
HF..ms.2..FF
T. 3977.9±139
50.34 
7814.47±151
41.85 
4361.12±16
171.07 
-
139.31±22
71.2 
-
1494.26±3
601.48 
-
1201.62±4
576.05 
2564.07±88
17.67 
-
1525.68±16
053.38 
282.69±10
06.41 
-
4792.4±165
42.89 
119.3±240
0.34 
24.69±711
.14 
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HF..ms.2..AR. 
4463.08±14
100.6 
7741.14±135
09.72 
4041.64±14
520.01 
-
84.98±232
3.08 
-
2077.73±4
030.26 
-
1520.56±5
329.64 
3168.47±10
106.6 
61±15572.0
4 
439.79±87
9.32 
-
3604.15±14
111.46 
111.81±24
28.67 
-
48.82±100
6.06 
VLF..log..FFT
. 0.87±2.42 1.33±1.98 0.49±2.07 0.17±2.04 -0.47±2.29 -0.52±1.59 1.61±1.53 1.03±1.67 0.96±1.34 -0.49±1.71 -0.56±1.79 -0.53±1.2 
VLF..log..AR. 1.12±2.58 1.45±2.5 0.51±1.92 0.06±2.45 -0.7±2.3 -0.66±2.16 1.39±1.11 0.91±2.19 0.93±1.35 -0.27±1.78 -0.49±1.56 -0.21±1.77 
LF..log..FFT. 1.27±3.17 1.95±2.75 0.7±2.56 0.43±3.22 -0.65±2.81 -0.87±2.61 1.47±1.55 1.28±2.19 1.46±1.67 0.13±1.68 0.12±1.02 -0.22±1.91 
LF..log..AR. 1.35±3.24 1.83±2.48 0.75±2.23 0.19±2.93 -0.65±2.78 -0.74±2.41 1.52±1.2 1.21±2.8 1.36±2.02 0.01±2.21 0.03±0.96 -0.14±2.43 
HF..log..FFT. 1.12±3.46 1.41±3.13 0.56±2.89 0.11±3 -0.54±2.65 -0.34±2.23 1.44±1.76 0.71±2.35 1.16±1.84 -0.43±2.6 -0.02±1.6 0.26±2.27 
HF..log..AR. 1.02±3.47 1.36±2.89 0.19±2.14 0.18±2.92 -0.79±2.79 -0.66±2.29 1.51±1.58 0.87±2.56 1.06±2 -0.42±2.85 -0.03±1.57 -0.02±2.41 
VLF.....FFT. 
-1.5±14.14 -0.48±9.83 -0.91±10.94 
1.05±13.0
2 0.35±10.93 -2.08±8.56 -2.7±10.21 -0.64±12.38 
-
4.11±12.96 -0.16±15.07 
-
2.51±16.0
6 
-
4.04±10.4
6 
VLF.....AR. 
0.62±11.34 -0.36±11.16 1.47±7.57 -1.2±10.44 0.26±10.09 0.63±8.75 -3.97±9.39 -1.28±9.01 
-
4.77±13.68 2.21±13.93 
-
3.17±20.9
3 -2.22±8.54 
LF.....FFT. 
4.36±20.87 10.72±24.36 3.95±22.57 
4.96±23.6
1 
-
1.99±29.16 
-
8.53±18.27 3.41±27.12 
11.39±24.0
3 8.98±19.17 9.76±23.53 3.81±25.8 
-
6.29±15.7
5 
LF.....AR. 
5.68±18.98 9.28±24.96 
10.37±22.4
4 
1.49±23.8
8 3.23±31.11 
-
1.46±23.46 4.05±24.45 7.67±23.51 8.89±21.23 5.3±21.48 
1.29±21.6
3 
-
1.58±13.7
9 
HF.....FFT. 
-2.72±27.07 -9.94±31.43 -2.82±27.92 -5.87±29.9 1.69±34.64 
10.56±18.7
3 -0.58±32.13 
-
10.48±31.3
3 
-
4.76±28.28 -9.42±36.24 
-
1.29±38.9
1 
10.11±22.
27 
HF.....AR. 
-6.13±25.3 -8.58±33.67 
-
11.63±26.6
3 
-
0.17±30.8
8 
-
3.41±39.01 0.83±29.01 -0.02±31.31 -6.33±27.65 
-
4.02±27.92 -7.48±32.85 
1.82±40.1
6 3.75±18.7 
LF..n.u...FFT. 
3.5±25.77 11.26±30.51 3.68±27.46 
6.42±28.2
1 
-
1.84±34.32 
-
10.65±18.3
4 1.2±31.44 11.09±30 6.56±26.14 10.7±33.62 
3.44±35.9
8 
-
8.81±20.0
1 
LF..n.u...AR. 
6.42±24.57 9.68±32.95 
12.24±26.4
1 
1.02±30.3
4 3.94±39.1 
-
1.06±29.39 0.71±30.49 7.27±28.46 5.71±28.46 8.16±31.03 
0.59±35.9
2 
-
3.15±18.3
8 
HF..n.u...FFT. 
-3.36±25.63 -10.92±30.39 -3.45±27.3 
-
6.26±28.1
1 1.9±34.1 10.6±18.18 -1.07±31.11 
-
10.81±29.6
2 
-
6.44±25.95 
-
10.51±33.3
7 
-
3.43±35.3
5 8.6±19.71 
HF..n.u...AR. 
-6.24±24.32 -9.3±32.89 -12.02±26.2 
-
0.87±30.3
3 -3.85±38.7 1.06±29.04 -0.64±30.23 -7.2±28.23 -5.6±28.35 -8.13±30.87 
-
0.64±35.5
8 
3.11±18.2
4 
To-
tal.power..ms.
2..FFT. 
4906.31±19
555.87 
11085.92±20
081.97 
5546.01±21
348.24 
375.21±35
32.69 
-
1635.28±7
319.38 
-
2493.84±6
823.85 
4271.37±13
831.21 
-
336.86±194
51.73 
694.09±21
05.22 
-
5330.88±17
433.03 
-
217.03±28
51.4 
-
107.62±14
50.89 
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To-
tal.power..ms.
2..AR. 
5943.88±20
373.8 
11762.34±19
028.78 
6158.46±20
785.94 
322.69±38
49.54 
-
2278.65±7
592.45 
-
2739.42±7
914.85 
5158.46±15
452.05 
1799.16±20
536.25 
1153.94±1
732.97 
-
3958.44±15
517.15 
-
106.2±297
9.45 
-
131.73±16
73.05 
LF.HF.ra-
tio.FFT. -0.38±3.15 -2.25±11.82 0.06±1.94 -2.03±9.27 0.31±1.98 2.27±10.48 -0.3±1.84 0.37±1.4 0.26±1.36 0.75±2.04 0.66±1.88 -0.25±0.87 
LF.HF.ra-
tio.AR. 0.1±1.65 -1.4±7.85 0.56±1.08 -1.64±7.1 0.39±2 1.83±8.16 -0.37±2.04 0.35±1.52 0.28±1.65 0.78±2.1 0.64±1.99 -0.06±0.97 
01 means difference between one day before surgery and 1 day after surgery. 02 means difference between one day before sur-
gery and 2 day after surgery, 03 means difference between one day before surgery and 3 day after surgery, 12 means difference 
between 1 day after surgery and 2 day after surgery, 13 means difference between 1 day after surgery and 3 day after surgery and 
23 means difference between 2 day after surgery and 3 day after surgery. Significant differences between different measurement 
days were not found. 
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Results of interventions for surgery group PR including all HRV parameters: 
 
 
Parameters                                                                            Mean ± SD 
                                                         A                                                      B 
             01          02          12             01          02         12 
PNS.index 0.4±1.09 0.22±1.51 -0.14±1.01 -0.03±2.32 0.29±2.24 0.42±1.79 
SNS.index -0.76±2.62 -1.1±2.79 -0.46±3.36 -1.27±3.01 -1.54±2.12 -0.41±2.04 
Stress.index -4.42±16.25 -6±14.8 -2.4±21.49 -8.14±13.89 -7.69±11.05 -0.1±10.84 
Mean.RR...ms. 28.61±123.64 51.51±124.1 18.82±68.13 26.44±157.36 68.08±121.42 55.87±93.87 
STD.RR..ms. 10±19.35 5.58±21.14 -3.85±22.72 2.37±36.14 -0.95±52.81 -2.16±51.91 
Mean.HR..beats.min. -1.56±8.65 -4.03±9.2 -1.8±5.27 -2.2±13.23 -5.37±10.24 -4.12±8.84 
STD.HR..beats.min. 1.02±2.08 0.58±2 -0.26±1.91 0.11±2.65 -1.69±8.37 -1.8±8.29 
Min.HR..beats.min. -3.71±11.26 -4.95±10.52 -1.58±8.42 -3.38±14.71 -5.92±8.61 -3.26±8.08 
Max.HR..beats.min. 0.96±12.92 -0.28±12.02 -0.57±7.61 0.67±14.15 -5.46±22.35 -7.11±20.72 
RMSSD..ms. 11.05±27.4 2.94±38.36 -7.59±38.23 -1.03±54.96 -0.94±68.31 1.47±65.5 
NNxx..beats. 10.53±56.69 -1.89±158.2 -13.5±169.31 -5.79±127.64 -31.74±187.77 -23.83±140.48 
pNNxx.... 2.54±10.74 1.2±23.39 -1.73±24.09 -0.72±20.24 -2.7±22.24 -1.39±16.96 
RR.tri.index 0.84±2.71 1.71±2.26 0.73±2.48 1.59±4.92 0.48±7.32 -1.05±4.8 
TINN..ms. 45.53±253.99 29.21±216.92 0.72±303.89 37.26±366.48 98.95±271.29 92.33±314.54 
SD1..ms. 7.82±19.39 2.08±27.15 -5.37±27.05 -0.73±38.89 -0.66±48.33 1.05±46.35 
SD2..ms. 11.15±20.33 9.2±17.58 -1.04±18.94 5.37±34.72 -1.37±58.06 -5.4±58.16 
SD2.SD1.ratio 0.21±0.55 0.04±0.75 -0.23±0.7 0.05±0.78 -0.24±1.16 -0.3±0.83 
Approximate.en-
tropy..ApEn. -0.08±0.38 0.13±0.43 0.19±0.49 0.03±0.34 -0.05±0.31 -0.08±0.48 
Sample.en-
tropy..SampEn. -0.09±0.62 0.2±0.64 0.23±0.77 0.01±0.47 -0.1±0.5 -0.12±0.73 
alpha.1 0.1±0.28 0.06±0.36 -0.03±0.33 0.08±0.37 -0.03±0.42 -0.12±0.32 
alpha.2 0±0.15 0.01±0.19 -0.01±0.16 -0.03±0.26 -0.07±0.2 -0.03±0.17 
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VLF..Hz..FFT. 0±0.01 0±0.01 0±0.01 0±0.01 0±0.01 0±0 
VLF..Hz..AR. 0±0.01 0±0.02 0.01±0.01 0±0.01 0.01±0.02 0.01±0.02 
LF..Hz..FFT. 0±0.02 0±0.03 0±0.03 0±0.05 0.01±0.04 0.02±0.04 
LF..Hz..AR. 0±0.03 0±0.04 0±0.05 0±0.05 0.01±0.04 0.01±0.04 
HF..Hz..FFT. 0.03±0.1 0.02±0.09 -0.02±0.12 -0.01±0.08 0.01±0.08 0.02±0.08 
HF..Hz..AR. -0.01±0.11 0.02±0.1 0.01±0.14 0±0.1 0.02±0.06 0.03±0.08 
VLF..ms.2..FFT. 33.61±144.47 56.83±83.68 25.72±110.91 -13.94±194.08 -9.65±151.51 20.44±156.64 
VLF..ms.2..AR. 67.98±155.09 61.91±108.36 -1.89±111.7 -69.21±334.14 -63.87±324.96 17.63±328.03 
LF..ms.2..FFT. 
195.82±757.1
7 237.77±718.58 53.48±574.02 
-
275.91±1633.7
7 24.67±1365.27 
430.65±2158.3
4 
LF..ms.2..AR. 259.05±528.1
6 154.39±586.3 -82.9±512.48 33.35±1287.84 
146.31±1450.2
7 
214.18±1682.6
9 
HF..ms.2..FFT. 
433.1±968.83 
246.42±1069.2
2 -84.67±588.44 -418±1741.89 
-
883.74±3334.8
1 
-
377.76±3596.3
1 
HF..ms.2..AR. 
423.43±912.4
1 
221.89±1253.8
2 -144.38±689.98 
-
189.22±1937.6
1 
-
742.17±3530.6
6 -537.4±3841.53 
VLF..log..FFT. 0.89±2.27 0.83±1.55 -0.1±2.06 0.58±1.94 0.23±1.88 -0.16±1.67 
VLF..log..AR. 0.94±2 0.72±1.45 -0.18±2.11 0.55±2.03 0.31±1.97 -0.16±2.05 
LF..log..FFT. 0.81±2.36 0.74±1.66 0.01±2.67 0.72±2.33 0.63±2.39 0.04±2.28 
LF..log..AR. 0.91±2.09 0.7±1.7 -0.14±2.48 0.96±2.19 0.96±2.36 0.07±2.43 
HF..log..FFT. 0.74±1.91 0.6±1.87 0.01±2.51 0.38±2.78 0.71±3.02 0.47±2.55 
HF..log..AR. 0.66±1.84 0.54±1.97 0.02±2.46 0.73±2.86 1.03±3.03 0.37±2.62 
VLF.....FFT. 1.47±10.21 1.25±11.64 -1.29±7.86 -1.49±12.22 -5.14±12.52 -2.2±10.56 
VLF.....AR. 1.59±8.05 1.47±8.96 -0.7±7.07 -2.2±10.4 -6.8±11.6 -3.85±8.53 
LF.....FFT. 0.76±19.51 3.04±22.24 1.14±12.45 7.2±17.27 3.42±21.76 -4.73±17.2 
LF.....AR. 3.72±16.98 3.41±19.37 -1.49±11.45 4.75±17.32 4.13±20.4 -0.78±15.05 
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HF.....FFT. -2.25±23.86 -4.25±26.23 0.22±13.81 -5.61±24.36 1.68±29.28 6.79±20.08 
HF.....AR. -5.23±20.92 -4.82±26.13 2.17±12.59 -2.53±25.03 2.66±28.92 4.56±19.04 
LF..n.u...FFT. 1.26±24.35 4.19±25.64 1.09±13.75 6.31±22.31 -0.7±28.94 -6.9±19.63 
LF..n.u...AR. 4.93±22.06 4.46±26.08 -2.13±12.49 3.6±23.15 -0.22±28.52 -3.62±18.97 
HF..n.u...FFT. -1.29±24.17 -4.16±25.4 -1.02±13.57 -6.2±22.12 0.66±28.81 6.76±19.48 
HF..n.u...AR. -4.85±22 -4.41±25.91 2.11±12.23 -3.58±23.02 0.23±28.45 3.56±18.82 
To-
tal.power..ms.2..FFT
. 
666.89±1667.
1 
543.39±1711.7
8 -8.3±1205.48 
-
711.63±3419.5
5 
-
874.78±4693.0
9 71.13±5627.49 
To-
tal.power..ms.2..AR. 752.68±1439.
3 
440.53±1838.0
8 
-
229.53±1279.0
5 -226.1±3339.23 
-
666.74±5064.6
3 -311.7±5712.39 
LF.HF.ratio.FFT. 0.01±3.95 -0.57±5.3 -0.7±2.23 -0.54±4.22 -0.92±3.93 -0.4±4.38 
LF.HF.ratio.AR. 0.59±2.49 -0.29±3.78 -1±2.93 -0.5±2.67 -1.11±4.03 -0.68±3.67 
01 means difference between one day before surgery and 1 day after surgery. 02 means difference between one day before sur-
gery and 2 day after surgery, 03 means difference between one day before surgery and 3 day after surgery, 12 means difference 
between 1 day after surgery and 2 day after surgery, 13 means difference between 1 day after surgery and 3 day after surgery and 
23 means difference between 2 day after surgery and 3 day after surgery. Significant differences between different measurement 
days were not found. 
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Results of interventions for surgery group PM including all HRV parameters: 
 
Parameters                                                                                  Mean ± SD 
                                                                    A                                                              B 
       01            02          12           01          02           12 
PNS.index 0.18±1.85a 0.16±1.69 0.01±2.06 -0.92±1.64 -0.1±1.63 0.59±1.71 
SNS.index -0.43±1.68a -1.08±2.08 -0.72±2.41 0.67±1.54 -0.04±2.13 -0.58±1.37 
Stress.index -3.97±6.77a -5.61±11.19 -1.78±13.62 1.46±7.82 -1.02±10.32 -1.7±6.58 
Mean.RR...ms. -17.94±99.13 49.92±120.45 76.44±106.58 -32.65±141.7 6.44±136.05 32.99±97.58 
STD.RR..ms. 11.07±31.18a 1.7±39.98 -9.65±41.01 -11.22±33.76 -0.99±27.78 5.34±37.26 
Mean.HR..beats.mi
n. 1.45±8 -4.3±10.01 -6.38±10.11 3.35±11.42 0.11±10.22 -2.93±7.42 
STD.HR..beats.min. 1.51±3.41a -0.16±4.25 -1.73±4.44 -1.19±4.54 -0.41±1.82 0.71±4.93 
Min.HR..beats.min. -0.94±8.2 -5.3±10.64 -4.85±9.31 2.51±10.66 -0.12±10.57 -1.68±7.81 
Max.HR..beats.min. 5.44±14.06 -2.32±16.02 -8.49±18.65 0.11±19.23 -0.15±11.75 -0.55±17.21 
RMSSD..ms. 13.42±49.16a -0.43±51.03 -13.98±59.33 -20.11±57.1 -0.69±44.14 11.61±60.7 
NNxx..beats. 17.6±78.92 -47.95±170.33 -68.05±187.39 -14.77±120.06 9.73±33.77 38.6±116.29 
pNNxx.... 1.91±9.95 -5.43±18.93 -7.62±20.5 -2.18±16.63 1.32±5.77 5.56±15.68 
RR.tri.index -0.02±1.7 -1.82±8.01 -2±8.19 -0.38±2.33 0.35±2.22 0.75±1.87 
TINN..ms. 123.75±198.96a 100.24±343.8 -20.6±282.55 -27.41±247.36 -23.55±321.54 -21.25±269.2 
SD1..ms. 9.49±34.79a -0.3±36.11 -9.89±41.98 -14.24±40.41 -0.49±31.24 8.22±42.95 
SD2..ms. 11.86±27.89 2.67±44.96 -9.6±41.66 -8.01±27.17 -1.2±25.16 2.67±32.02 
SD2.SD1.ratio 0.11±0.5 -0.03±0.52 -0.17±0.68 0.2±0.49 -0.04±0.87 -0.22±0.86 
Approximate.en-
tropy..ApEn. -0.1±0.27 -0.12±0.43 -0.03±0.46 0.06±0.31 0.06±0.38 0.03±0.37 
Sample.en-
tropy..SampEn. -0.19±0.41 -0.2±0.68 -0.02±0.73 0.09±0.53 0.12±0.61 0.08±0.6 
alpha.1 0.12±0.21 0.03±0.19 -0.09±0.29 0.13±0.29 0±0.35 -0.12±0.33 
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alpha.2 0±0.16 -0.06±0.15 -0.06±0.22 -0.01±0.17 -0.03±0.14 -0.04±0.14 
VLF..Hz..FFT. 0±0.01 0±0.01 0±0.01 0±0 0±0.01 0±0.01 
VLF..Hz..AR. 0±0.02 0.01±0.02 0.01±0.01 0±0.02 0.01±0.02 0±0.02 
LF..Hz..FFT. 0.01±0.04 0.01±0.04 0±0.02 0.01±0.03 0±0.04 -0.01±0.04 
LF..Hz..AR. 0±0.05 0.01±0.04 0.01±0.05 0±0.05 0.01±0.04 0.02±0.05 
HF..Hz..FFT. 0±0.06 -0.01±0.07 -0.01±0.06 0.02±0.09 0±0.06 -0.02±0.07 
HF..Hz..AR. -0.01±0.06 -0.01±0.1 0.01±0.08 0±0.08 -0.01±0.07 -0.01±0.08 
VLF..ms.2..FFT. 39.62±127.26 20.68±154.84 -16.38±149.27 7.06±67.45 94.48±271.7 32.73±172.34 
VLF..ms.2..AR. 66.75±169.25 -53.32±457.87 -124.71±443.62 -46.25±202.84 -16.02±335.4 -28.15±299.44 
LF..ms.2..FFT. 
599.69±1234.4 
-
187.89±2920.7
3 -805±2536.16 -51.15±1078.45 
286.74±2058.6
6 
-
168.17±1025.5
8 
LF..ms.2..AR. 
461.59±898.94 
-
175.63±2333.9
9 
-
655.97±2109.62 
-
563.27±3005.16 
-
144.01±2330.7
1 33.78±2288.96 
HF..ms.2..FFT. 
414.02±2315.5 
-
366.72±3324.6
9 
-
801.84±3207.87 
-
1579.37±4862.4
6 
665.15±5821.6
2 
931.89±3741.4
4 
HF..ms.2..AR. 
331.24±1887.66 
-
548.07±3167.8
1 
-
909.44±3187.36 
-
1411.96±3807.3
5 
-
68.37±3911.57 
593.85±3019.8
9 
VLF..log..FFT. 0.53±1.54 0.47±1.95 0±1.76 -0.02±1 0.41±1.16 0.16±0.95 
VLF..log..AR. 0.57±1.34a 0.48±2.02 -0.09±1.91 -0.24±0.97 0.15±1.11 0.24±1.12 
LF..log..FFT. 0.79±1.46a 0.83±2.3 0.05±2.25 0.13±1.37 0.2±1.43 -0.19±1.25 
LF..log..AR. 0.77±1.35 0.89±2.14 0.1±2.09 0.04±1.3 0.26±1.29 0.01±1.28 
HF..log..FFT. 0.52±2.42 0.7±2.55 0.19±2.83 -0.45±1.54 0.02±1.72 0.26±1.43 
HF..log..AR. 0.51±1.87 0.75±2.45 0.25±2.5 -0.51±1.49 0.11±1.59 0.52±1.32 
VLF.....FFT. -0.35±9.34 -3.73±10.68 -3.02±13.53 -0.09±8.99 0.64±6.67 0.78±7.1 
VLF.....AR. -0.42±8.03 -3.3±7.78 -2.95±9.75 -0.81±8.09 -0.11±5.45 0.75±7.36 
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LF.....FFT. 4.96±21.66 5.74±15.04 0.48±23.04 11.19±17.87 4.73±21.22 -7.28±22.54 
LF.....AR. 5.39±18.34 5.75±14.97 -0.07±19.02 10.58±16.77 3.96±19.38 -8.21±21.19 
HF.....FFT. -4.61±25.16 -2±18.1 2.56±29.79 -10.94±21.98 -5.3±22.37 6.42±24.85 
HF.....AR. -4.97±20.09 -2.46±18.17 3.01±25.11 -9.7±20.18 -3.75±20.49 7.51±22.98 
LF..n.u...FFT. 4.87±25.66 2.65±17.1 -2.37±29.28 11.92±21.39 5.55±22.84 -6.83±25.13 
LF..n.u...AR. 5.56±21.16 3.44±18.78 -2.74±25.17 11.26±20.43 4.51±22.24 -8.19±24.5 
HF..n.u...FFT. -4.87±25.51 -2.62±17.05 2.39±29.17 -11.76±21.32 -5.47±22.77 6.75±25.01 
HF..n.u...AR. -5.56±21.06 -3.45±18.7 2.73±25.08 -11.18±20.31 -4.39±22.08 8.23±24.29 
To-
tal.power..ms.2..FF
T. 
1049.18±3512.0
9 
-
538.09±6305.7
1 
-
1623.45±5617.7
8 
-
1635.71±5792.6
9 1043±7963.37 801.96±4582.6 
To-
tal.power..ms.2..AR. 
859.74±2784.07 
-
778.74±5909.8
3 
-
1692.07±5535.6
5 
-
2027.09±6618.3
4 
-
228.45±6485.4 
604.28±4890.0
4 
LF.HF.ratio.FFT. 0.44±2.79 0.28±1.53 -0.16±2.68 0.8±2.37 -1.03±6.02 -1.56±6.1 
LF.HF.ratio.AR. 0.22±1.79 -0.17±1.78 -0.44±2.38 0.53±1.38 -1.05±5.79 -1.62±5.95 
01 means difference between one day before surgery and 1 day after surgery. 02 means difference between one day before sur-
gery and 2 day after surgery, 03 means difference between one day before surgery and 3 day after surgery, 12 means difference 
between 1 day after surgery and 2 day after surgery, 13 means difference between 1 day after surgery and 3 day after surgery and 
23 means difference between 2 day after surgery and 3 day after surgery. Significant differences between PREOP and 1POP: aP < 
0.05. Significant differences between other measurement days were not found.
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APPENDIX B: RESULTS OF ALL GROUPS 
Results for all groups including all HRV parameters: 
 
 
Parameters                                         Mean ± SD 
PREOP 1POP 2POP 3POP 
PNS.index 0.81±2.66 0.82±4.88 0.27±2.35 0.85±2.59 
SNS.index 0.41±1.75ab 1.1±2.35 1.44±2.37 1.11±2.27 
Stress.index 11.5±7.81ab 15.83±11.32 16.59±12.06 12.75±10.49 
Mean.RR...ms. 919.45±156.2
9bc 
899.29±179.6
5de 
846.8±134.3
6 
799.04±182.
11 
STD.RR..ms. 50.58±53.02 46.95±96.74 40.79±47.96 56.7±53.67 
Mean.HR..beat
s.min. 
67.19±11.79b
c 
69.02±12.77d
e 
72.65±11.71 78.35±15.6 
STD.HR..beats
.min. 
3.97±4.3 4.01±8.21 3.89±5.11 6.55±8.02 
Min.HR..beats.
min. 
59.18±10.93b
c 
62.55±11.71d 65.24±11.41 67.77±13 
Max.HR..beats.
min. 
78.19±14.39b
c 
78.37±16.37 82.17±15.44 89.95±23.03 
RMSSD..ms. 66.58±82.72 66.97±159.41 54.95±72.9 80.75±79.05 
NNxx..beats. 87.3±147.98 68.14±165.84 77.34±165.0
5 
155.09±248.
35 
pNNxx.... 13.6±22.14 10.1±21.59 10.73±21.79 18.85±27.41 
RR.tri.index 8.12±7.54a 6.45±8.23 6.32±6.96 8.16±8.99 
TINN..ms. 381.93±327.9
8 
339.42±472 296.88±278.
76 
415.97±300.
08 
SD1..ms. 47.12±58.54 47.4±112.9 38.88±51.58 57.14±55.94 
SD2..ms. 52.15±48.72a 44.57±78.63 41.14±45.43 55.53±51.97 
SD2.SD1.ratio 1.52±0.68 1.4±0.67 1.56±0.87 1.2±0.59 
Approxi-
mate.en-
tropy..ApEn. 
1.19±0.3 1.17±0.35 1.16±0.39 1.1±0.45 
Sample.en-
tropy..SampEn. 
1.39±0.51 1.35±0.55 1.32±0.58 1.19±0.62 
alpha.1 0.87±0.32a 0.78±0.34 0.85±0.38 0.68±0.28 
alpha.2 0.36±0.15b 0.39±0.19 0.42±0.18 0.37±0.22 
VLF..Hz..FFT. 0.04±0 0.04±0 0.04±0 0.04±0 
VLF..Hz..AR. 0.04±0.01b 0.04±0.01 0.03±0.02 0.03±0.01 
LF..Hz..FFT. 0.08±0.03 0.07±0.03 0.07±0.03 0.08±0.04 
LF..Hz..AR. 0.09±0.03 0.1±0.04 0.09±0.04 0.11±0.04 
HF..Hz..FFT. 0.24±0.07c 0.24±0.07 0.25±0.07 0.27±0.08 
HF..Hz..AR. 0.23±0.08 0.24±0.08 0.24±0.08 0.24±0.09 
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VLF..ms.2..FFT
. 
111.58±192.9
7b 
462.93±4142.
91 
58.92±104.0
5 
76.91±107.7
9 
VLF..ms.2..AR. 229.91±434.8
6 
754.75±6385.
82 
169.87±396.
53 
228.47±349.
86 
LF..ms.2..FFT. 1522.38±361
2.51 
4414.9±3643
6.45 
904.43±252
6.22 
1355.11±21
58.97 
LF..ms.2..AR. 1572.2±3614.
95 
4021.29±325
81.26 
901.83±247
5.53 
1282.6±194
5.98 
HF..ms.2..FFT. 2886.01±840
5.42 
4132.1±2624
2.56 
2080.38±69
84.29 
2901.48±48
79.22 
HF..ms.2..AR. 2948.16±815
5.79 
3896.6±2383
5.32 
2082.77±64
30.79 
3214.68±52
52.32 
VLF..log..FFT. 3.81±1.42ab 3.19±1.66 3.13±1.43 3.19±1.69 
VLF..log..AR. 4.42±1.46ab 3.77±1.74 3.78±1.65 4.1±1.83 
LF..log..FFT. 5.86±1.71ab 5.1±2.04 4.96±1.99 5.16±2.42 
LF..log..AR. 5.96±1.71ab 5.09±2.01 5.01±1.95 5.42±2.24 
HF..log..FFT. 5.83±2.04 5.29±2.29 5.12±2.4 5.57±2.85 
HF..log..AR. 5.99±2.02b 5.38±2.25 5.19±2.37 6.05±2.6 
VLF.....FFT. 8.2±6.76 9±9.1 9.68±9.52 8.93±9.99 
VLF.....AR. 10.54±6.61 11.52±8.12 12.44±8.33 10.43±10.01 
LF.....FFT. 45.66±18.26a
b 
40.59±19.38 39.9±20.11 35.75±15.22 
LF.....AR. 43.39±17.28a
bc 
37.94±18.5 38.48±19.33 31.46±14.28 
HF.....FFT. 45.95±21.9 50.14±24.48 50.13±25.36 54.94±21.64 
HF.....AR. 45.85±20.96 50.27±23.75 48.8±24.44 57.76±20.56 
LF..n.u...FFT. 50.67±21.73 46.08±23.9 45.81±25.02f 40.79±20.36 
LF..n.u...AR. 49.44±21.19 44.36±23.48 45.47±24.86 36.6±19.5 
HF..n.u...FFT. 49.12±21.59 53.63±23.7 53.88±24.82f 58.81±20.15 
HF..n.u...AR. 50.33±21.03 55.35±23.3 54.21±24.69 63.02±19.33 
To-
tal.power..ms.2
..FFT. 
4528.37±119
03.92 
9020.16±666
77.46 
3054.05±89
56.33 
4351.8±682
9.3 
To-
tal.power..ms.2
..AR. 
4761.66±120
76.82 
8682.45±626
98.85 
3163.79±87
92.19 
4743.24±71
73.44 
LF.HF.ra-
tio.FFT. 
1.79±2.19 1.8±3.18 2.43±5.73 1.1±1.44 
LF.HF.ratio.AR. 1.58±1.72 1.5±2.25 2.22±4.49 0.84±0.96 
Significant differences between PREOP and 1POP: aP < 0.01. Significant differ-
ences between PREOP and 2POP: bP < 0.01. Significant differences between 
PREOP and 3POP: cP < 0.01. Significant differences between 1POP and 
2POP: dP < 0.01. Significant differences between 1POP and 3POP: eP < 0.01. 
Significant differences between 2POP and 3POP: fP < 0.01. 
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APPENDIX D: RESULTS OF DIFFERENT GROUPS 
Results for surgery group C including all HRV parameters: 
 
 
Parameters                                         Mean ± SD 
PREOP 1POP 2POP 3POP 
PNS.index 2.04±3.45 0.67±2.63 0.8±2.79 0.79±2.65 
SNS.index -0.22±1.72bc 1.16±2.61 1.1±2.44 1.23±2.32 
Stress.index 9.55±8.06 15.6±12.29 14.83±12 13.31±10.78 
Mean.RR...ms. 965.88±160.5
3abc 
867.87±166.
54 
815.38±124.6 797.55±185.
8 
STD.RR..ms. 73.11±73.69 43.05±48.43 48.42±55.72 56.08±54.17 
Mean.HR..beat
s.min. 
63.83±10.74b
c 
71.72±14.58 75.33±11.93 78.61±15.91 
STD.HR..beats
.min. 
5.24±5.24 4.08±7.01 4.83±5.08 6.55±8.22 
Min.HR..beats.
min. 
55.43±10.98a
bc 
64.59±12.59 66.67±12.69 67.94±13.12 
Max.HR..beats.
min. 
75.04±12.74b
c 
80.22±19.11 85.24±14.14 89.72±23.45 
RMSSD..ms. 100.93±114.7
3 
63.9±79.18 70.97±89.51 79.65±80.02 
NNxx..beats. 131.43±175.6 76±220.09 83.94±156.28 149.94±244.
02 
pNNxx.... 21.43±28.34 10.03±23.77 11.5±20.33 18.15±26.41 
RR.tri.index 10.92±10.15b 5.18±7.96 5.51±6.23 7.64±8.44 
TINN..ms. 499.22±406.1
2 
362.13±315.
64 
362.06±274.4 411.13±311.
6 
SD1..ms. 71.43±81.2 45.22±56.04 50.22±63.34 56.36±56.63 
SD2..ms. 73.03±67.24a 38.78±41.34 45.69±47.83 54.99±52.28 
SD2.SD1.ratio 1.33±0.59 1.23±0.67 1.24±0.73 1.23±0.61 
Approxi-
mate.en-
tropy..ApEn. 
1.14±0.29 1±0.42 1.02±0.43 1.08±0.46 
Sample.en-
tropy..SampEn. 
1.33±0.54 1.09±0.59 1.06±0.6 1.16±0.63 
alpha.1 0.78±0.31 0.7±0.35 0.7±0.37 0.7±0.28 
alpha.2 0.28±0.14 0.37±0.24 0.38±0.19 0.36±0.22 
VLF..Hz..FFT. 0.04±0 0.04±0 0.04±0 0.04±0 
VLF..Hz..AR. 0.04±0.01 0.04±0.01 0.03±0.01 0.03±0.01 
LF..Hz..FFT. 0.09±0.04 0.07±0.03 0.07±0.03 0.08±0.04 
LF..Hz..AR. 0.1±0.04 0.11±0.04 0.1±0.04 0.11±0.04 
HF..Hz..FFT. 0.21±0.06abc 0.26±0.08 0.27±0.07 0.26±0.08 
HF..Hz..AR. 0.21±0.08b 0.25±0.09 0.26±0.09 0.24±0.09 
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VLF..ms.2..FFT
. 
129.62±208 48.22±101.9
3 
54.73±111.98 74.61±108.8
2 
VLF..ms.2..AR. 380.27±616.7 143.58±374.
22 
146.5±268.24 232.4±360.6
7 
LF..ms.2..FFT. 2519.94±489
4.49 
1105.56±30
18.39 
689.99±1267.
62 
1370.81±22
12.47 
LF..ms.2..AR. 2958.37±543
3.56b 
1079.2±275
6 
731.64±1174.
03 
1294.43±19
87 
HF..ms.2..FFT. 5928.77±132
85.7 
1849.6±504
7.88 
3487.97±109
53.27 
2905.97±49
97.91 
HF..ms.2..AR. 6337.8±1314
7.07 
1945.23±50
14.57 
3206.74±929
4.75 
3246.19±53
92.23 
VLF..log..FFT. 3.88±1.54ab 2.7±1.53 2.75±1.68 3.1±1.71 
VLF..log..AR. 4.79±1.73ab 3.46±1.74 3.65±1.85 4.06±1.88 
LF..log..FFT. 6.26±2.01ab 4.9±2.21 4.67±2.17 5.1±2.47 
LF..log..AR. 6.45±2.07abc 4.94±2.19 4.98±2.11 5.38±2.29 
HF..log..FFT. 6.5±2.29 5.26±2.41 5.48±2.59 5.45±2.91 
HF..log..AR. 6.7±2.28 5.38±2.4 5.61±2.51 5.97±2.66 
VLF.....FFT. 6.3±6.44 8.31±10.83 6.86±8.31 9.25±10.36 
VLF.....AR. 8.81±6.37 10.52±9.78 9.71±7.29 10.7±10.36 
LF.....FFT. 41.32±18.32 37.04±18.99 30.16±19.72 36.64±15.58 
LF.....AR. 40.14±17.81 34.88±18.6 32.09±18.9 32.03±14.77 
HF.....FFT. 52.18±22.19 54.32±25.5 62.51±24.78 53.74±22.21 
HF.....AR. 50.83±20.84 54.25±25.26 57.8±23.78 56.93±21.24 
LF..n.u...FFT. 45.04±21.47 42.25±24.54 33.75±23.77 42.01±20.85 
LF..n.u...AR. 44.77±21 40.9±24.74 36.76±23.41 37.45±20.15 
HF..n.u...FFT. 54.75±21.34 57.4±24.37 65.76±23.56 57.61±20.64 
HF..n.u...AR. 54.99±20.84 58.73±24.54 62.79±23.32 62.18±19.98 
To-
tal.power..ms.2
..FFT. 
8595.83±181
08.94 
3010.48±81
23.56 
4251.3±1207
3.25 
4368.42±69
77.84 
To-
tal.power..ms.2
..AR. 
9700.3±1908
4.88 
3174.32±81
04.33 
4100.37±105
12.62 
4790.06±73
37.63 
LF.HF.ra-
tio.FFT. 
1.22±1.14 1.55±2.46 2.16±8.3 1.17±1.49 
LF.HF.ratio.AR. 1.22±1.19 1.34±1.78 1.77±5.48 0.89±0.99 
Significant differences between PREOP and 1POP: aP < 0.01. Significant differ-
ences between PREOP and 2POP: bP < 0.01. Significant differences between 
PREOP and 3POP: cP < 0.01. Significant differences between 1POP and 
2POP: dP < 0.01. Significant differences between 1POP and 3POP: eP < 0.01. 
Significant differences between 2POP and 3POP: fP < 0.01. 
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Results for surgery group PR including all HRV parameters: 
 
 
Parameters                                         Mean ± SD 
PREOP 1POP 2POP 
PNS.index 0.22±1.63 0.07±1.65 -0.15±1.78 
SNS.index 0.63±1.55b 1.6±2.4 1.97±2.42 
Stress.index 12.25±7.6b 18.36±12.92 19.49±13.49 
Mean.RR...ms. 898.59±150.24b 874.9±131.5 843.29±116.42 
STD.RR..ms. 38.66±32.83 32.94±33.96 33.29±40.54 
Mean.HR..beats.min
. 
68.68±12.09b 70.3±12.02 72.63±11.22 
STD.HR..beats.min. 3.45±4.33 2.96±4.16 3.41±6.05 
Min.HR..beats.min. 60.78±10.02b 64.16±10.91 66.17±9.67 
Max.HR..beats.min. 79.6±16.59 78.71±15.51 81.06±17.09 
RMSSD..ms. 48.36±48.31 43.76±49.94 43±56 
NNxx..beats. 73.05±157.84 74.24±172.03 71.89±186.84 
pNNxx.... 10.3±19.16 9.89±20.72 9.4±23.69 
RR.tri.index 6.77±5.09 5.65±4.84 5.29±5.76 
TINN..ms. 321.13±238.32 278.53±269.72 231.55±225.9 
SD1..ms. 34.22±34.18 30.96±35.34 30.43±39.62 
SD2..ms. 41.38±33.09 33.72±33.7 34.36±42.68 
SD2.SD1.ratio 1.54±0.71 1.41±0.7 1.67±0.93 
Approximate.en-
tropy..ApEn. 
1.23±0.27 1.25±0.3 1.18±0.4 
Sample.en-
tropy..SampEn. 
1.42±0.47 1.46±0.5 1.37±0.59 
alpha.1 0.89±0.3 0.8±0.36 0.88±0.39 
alpha.2 0.4±0.14 0.41±0.17 0.44±0.17 
VLF..Hz..FFT. 0.04±0.01 0.04±0 0.04±0 
VLF..Hz..AR. 0.04±0.01b 0.04±0.01d 0.03±0.02 
LF..Hz..FFT. 0.07±0.03 0.07±0.03 0.06±0.03 
LF..Hz..AR. 0.09±0.03 0.09±0.04 0.08±0.04 
HF..Hz..FFT. 0.26±0.08 0.24±0.07 0.24±0.07 
HF..Hz..AR. 0.25±0.07 0.25±0.08 0.23±0.08 
VLF..ms.2..FFT. 84.59±98.06 77.95±145.8 53.6±89.64 
VLF..ms.2..AR. 139.28±164 140.02±270.48 124.42±252.65 
LF..ms.2..FFT. 833.42±1853.15 912.76±2271.06 621.23±1431.52 
LF..ms.2..AR. 829.6±1716.06 710.55±1628.08 600.29±1314.92 
HF..ms.2..FFT. 936.35±1946.45 973.3±1802.66 1083.24±2517.8
8 
HF..ms.2..AR. 1067.53±2067.3
3 
960.21±1832.86 1137.21±2630.6
1 
VLF..log..FFT. 3.69±1.42 2.99±1.75 3.07±1.41 
VLF..log..AR. 4.19±1.38 3.44±1.82 3.58±1.62 
LF..log..FFT. 5.47±1.63b 4.76±2.15 4.67±1.99 
LF..log..AR. 5.61±1.58b 4.69±2.04 4.67±2 
HF..log..FFT. 5.39±1.68 4.88±2.26 4.58±2.33 
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HF..log..AR. 5.59±1.71 4.9±2.18 4.67±2.31 
VLF.....FFT. 9.71±7.52 9.52±9.19 11.96±10 
VLF.....AR. 11.66±6.97 11.91±7.35 14.61±8.89 
LF.....FFT. 45.4±18.32 41.44±20.54 42.57±20.07 
LF.....AR. 43.08±17.15 39.07±19.65 39.78±19.4 
HF.....FFT. 44.66±21.81 48.76±25.56 45.23±25.41 
HF.....AR. 45.02±21.17 48.73±24.56 45.35±25.1 
LF..n.u...FFT. 51.18±21.98 47.29±25.17 50.06±25.85 
LF..n.u...AR. 49.78±21.51 45.75±24.56 48.35±26.08 
HF..n.u...FFT. 48.56±21.83 52.4±24.95 49.69±25.67 
HF..n.u...AR. 49.97±21.36 53.93±24.36 51.36±25.92 
To-
tal.power..ms.2..FF
T. 
1859.07±3660.7
1 
1968.67±4036 1764.18±3810.9
6 
To-
tal.power..ms.2..AR. 
2041.65±3675.0
7 
1815.62±3472.6
5 
1868.64±4020.5
7 
LF.HF.ratio.FFT. 1.96±2.54 2.26±4.55 2.77±4.4 
LF.HF.ratio.AR. 1.75±2.18 1.74±2.96 2.51±3.77 
Significant differences between PREOP and 1POP: aP < 0.01. Significant differ-
ences between PREOP and 2POP: bP < 0.01. Significant differences between 
PREOP and 3POP: cP < 0.01. Significant differences between 1POP and 
2POP: dP < 0.01. Significant differences between 1POP and 3POP: eP < 0.01. 
Significant differences between 2POP and 3POP: fP < 0.01. 
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Results for surgery group PM including all HRV parameters: 
 
 
Parameters                                  Mean ± SD 
PREOP 1POP 2POP 
PNS.index 0.32±2.34 0.56±2.64 0.25±2.41 
SNS.index 0.73±1.85 0.67±1.95 1.23±2.26 
Stress.index 12.44±7.67 13.82±8.32 15.32±10.48 
Mean.RR...ms. 899.81±153.22 915.43±125.49d 873.29±152.5 
STD.RR..ms. 42.64±41.38 41.22±49.9 41.73±47.94 
Mean.HR..beats.mi
n. 
68.64±12.02 66.85±10.03d 70.67±11.83 
STD.HR..beats.min
. 
3.4±3.12 3.32±4.14 3.62±4.16 
Min.HR..beats.min. 60.85±11.12 60.74±9.12 63.36±11.83 
Max.HR..beats.min. 79.54±13.45 77.66±14.7 80.87±14.86 
RMSSD..ms. 54.53±67.36 55.12±80.71 53.59±71.88 
NNxx..beats. 63.67±102.56 59±112.05 77.23±154.28 
pNNxx.... 10.1±17.07 9.38±18.17 11.33±21.54 
RR.tri.index 7±6.28 6.97±6.84 7.83±8.21 
TINN..ms. 339.53±306.19 287.5±276.12 306.09±315.43 
SD1..ms. 38.59±47.67 39.01±57.12 37.92±50.87 
SD2..ms. 44.56±36.42 41.62±43.14 43.76±46.32 
SD2.SD1.ratio 1.66±0.69 1.52±0.62 1.7±0.85 
Approximate.en-
tropy..ApEn. 
1.21±0.32 1.22±0.31 1.24±0.32 
Sample.en-
tropy..SampEn. 
1.41±0.53 1.45±0.52 1.46±0.51 
alpha.1 0.94±0.33a 0.83±0.31 0.93±0.35 
alpha.2 0.38±0.15 0.39±0.17 0.42±0.18 
VLF..Hz..FFT. 0.04±0b 0.04±0d 0.03±0 
VLF..Hz..AR. 0.04±0.01 0.03±0.01 0.03±0.02 
LF..Hz..FFT. 0.08±0.03 0.06±0.03 0.07±0.03 
LF..Hz..AR. 0.09±0.03 0.09±0.04 0.08±0.04 
HF..Hz..FFT. 0.24±0.07 0.23±0.07 0.24±0.07 
HF..Hz..AR. 0.23±0.08 0.24±0.07 0.23±0.08 
VLF..ms.2..FFT. 120.73±239.71 77.71±193.79 66.75±111.52 
VLF..ms.2..AR. 186.85±395.79 160.73±493.97 227.42±551.62 
LF..ms.2..FFT. 1314.57±3454.1
8 
898.07±3778.01 1314.26±3707.73 
LF..ms.2..AR. 1092.56±2611.2 1037.12±4528.41 1294.97±3679.52 
HF..ms.2..FFT. 2117.22±5888.0
8 
2211.78±7643.36 1914.06±5788.44 
HF..ms.2..AR. 1832.8±4854.39 2127.52±6849.23 2081.95±6216.63 
VLF..log..FFT. 3.85±1.33 3.55±1.08 3.45±1.19 
VLF..log..AR. 4.32±1.25 4.12±1.15 4.05±1.51 
LF..log..FFT. 5.87±1.46 5.34±1.33 5.43±1.8 
LF..log..AR. 5.86±1.42 5.38±1.37 5.35±1.78 
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HF..log..FFT. 5.66±2.03 5.54±1.95 5.34±2.28 
HF..log..AR. 5.75±1.94 5.68±1.89 5.35±2.29 
VLF.....FFT. 8.43±6.05 8.95±7.77 9.76±9.6 
VLF.....AR. 10.98±6.32 11.8±7.61 12.54±8.14 
LF.....FFT. 49.46±17.73a 41.44±19.15 44.8±18.24 
LF.....AR. 46.34±16.83a 38.32±17.76 42.09±18.85 
HF.....FFT. 41.97±21.09 49.37±23.49 45.24±23.01 
HF.....AR. 42.51±20.55 49.67±22.42 45.15±23.11 
LF..n.u...FFT. 54.84±21.17 46.71±23.04 51.04±22.56 
LF..n.u...AR. 52.98±20.79 44.66±22.14 49.41±23.73 
HF..n.u...FFT. 45±21.04 53.03±22.83 48.75±22.41 
HF..n.u...AR. 46.83±20.64 55.1±21.98 50.36±23.54 
To-
tal.power..ms.2..FF
T. 
3556.71±9388.3
6 
3200.18±11501.2
2 
3302.96±9532.39 
To-
tal.power..ms.2..AR
. 
3118.77±7817.3
1 
3335.13±11715.8
4 
3611.36±10389.3
3 
LF.HF.ratio.FFT. 2.1±2.44 1.54±1.95 2.32±4.42 
LF.HF.ratio.AR. 1.72±1.61 1.38±1.81 2.3±4.35 
Significant differences between PREOP and 1POP: aP < 0.01. Significant differ-
ences between PREOP and 2POP: bP < 0.01. Significant differences between 
PREOP and 3POP: cP < 0.01. Significant differences between 1POP and 
2POP: dP < 0.01. Significant differences between 1POP and 3POP: eP < 0.01. 
Significant differences between 2POP and 3POP: fP < 0.01. 
 
